Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Alqahtani, Lamya Mesfer"'
Autor:
Babagi, Hisham Fawaz, Aljifri, Noor Mohammed M., Dali, Raghdah Suliman O., Jan, Noran Salah M., Alqahtani, Lamya Mesfer, Abusrrah, Wael Mohammed, Alfaya, Mansour Abdullah, Alqurus, Zahra Ali M., Alswilem, Abdullah Mansour
Publikováno v:
Pharmacophore; Nov/Dec2020, Vol. 11 Issue 6, p20-25, 6p
Publikováno v:
Kumar, Shashank; Pandey, Abhay K (2013) Chemistry and biological activities of flavonoids: an overview. En: The Scientific World Journal. Vol. 2013; Disponible en: 10.1155/2013/162750.
Stott, Colin; Guy, Geoffrey (2004) Cannabinoids for the pharmaceutical industry. En: Euphytica. Vol. 140; No. 1/2; pp. 83-93; 00142336; Consultado en: 2020/07/05/04:32:13. Disponible en: http://ezproxy.javeriana.edu.co:2048/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=a9h&AN=16342632&lang=es&site=eds-live. Disponible en: 10.1007/s10681-004-4757-8.
Gonçalves, Elaine C. D.; Baldasso, Gabriela M.; Bicca, Maíra A.; Paes, Rodrigo S.; Capasso, Raffaele; Dutra, Rafael C.; McPhee, Derek J. (2020) Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant. En: Molecules. Vol. 25; No. 7; pp. 1567 14203049; Consultado en: 2020/07/08/05:32:11. Disponible en: http://ezproxy.javeriana.edu.co:2048/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=a9h&AN=142828348&lang=es&site=eds-live. Disponible en: 10.3390/molecules25071567.
Russo, Ethan B. (2011) Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. En: British Journal of Pharmacology. Vol. 163; No. 7; pp. 1344-1364; 1476-5381; Consultado en: 2020/07/16/05:35:13. Disponible en: https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1476-5381.2011.01238.x. Disponible en: 10.1111/j.1476-5381.2011.01238.x.
Guindon, Josée; Hohmann, Andrea G. (2011) The endocannabinoid system and cancer: therapeutic implication. En: British Journal of Pharmacology. Vol. 163; No. 7; pp. 1447-1463; 1476-5381; Consultado en: 2020/07/16/05:38:00. Disponible en: https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1476-5381.2011.01327.x. Disponible en: 10.1111/j.1476-5381.2011.01327.x.
Aizpurua-Olaizola, Oier; Elezgarai, Izaskun; Rico-Barrio, Irantzu; Zarandona, Iratxe; Etxebarria, Nestor; Usobiaga, Aresatz (2017) Targeting the endocannabinoid system: future therapeutic strategies. En: Drug Discovery Today. Vol. 22; No. 1; pp. 105-110; 13596446; Consultado en: 2020/08/09/04:33:03. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S1359644616302926. Disponible en: 10.1016/j.drudis.2016.08.005.
Russo, Ethan B. (2016) Beyond Cannabis: Plants and the Endocannabinoid System. En: Trends in Pharmacological Sciences. Vol. 37; No. 7; pp. 594-605; 01656147; Consultado en: 2020/09/13/04:39:37. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0165614716300165. Disponible en: 10.1016/j.tips.2016.04.005.
Mechoulam, Raphael; Parker, Linda A. (2013) The Endocannabinoid System and the Brain. En: Annual Review of Psychology. Vol. 64; No. 1; pp. 21-47; 0066-4308, 1545-2085; Consultado en: 2020/09/13/05:02:20. Disponible en: http://www.annualreviews.org/doi/10.1146/annurev-psych-113011-143739. Disponible en: 10.1146/annurev-psych-113011-143739.
Pacher, Pál; Bátkai, Sándor; Kunos, George (2006) The Endocannabinoid System as an Emerging Target of Pharmacotherapy. En: Pharmacological Reviews. Vol. 58; No. 3; pp. 389-462; 0031-6997, 1521-0081; Consultado en: 2020/10/06/03:18:57. Disponible en: http://pharmrev.aspetjournals.org/lookup/doi/10.1124/pr.58.3.2. Disponible en: 10.1124/pr.58.3.2.
Pertwee, Roger G (2014) Handbook of Cannabis. : Oxford University Press, USA; 0-19-966268-1
Bisogno, T; Ligresti, A; Dimarzo, V (2005) The endocannabinoid signalling system: Biochemical aspects. En: Pharmacology Biochemistry and Behavior. Vol. 81; No. 2; pp. 224-238; 00913057; Consultado en: 2021/02/05/15:56:51. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0091305705001383. Disponible en: 10.1016/j.pbb.2005.01.027.
Ferber, Sari Goldstein; Namdar, Dvora; Hen-Shoval, Danielle; Eger, Gilad; Koltai, Hinanit; Shoval, Gal; Shbiro, Liat; Weller, Aron (2020) The “Entourage Effect”: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders. En: Current Neuropharmacology. Vol. 18; No. 2; pp. 87-96; 1570159X; Consultado en: 2021/02/06/16:17:44. Disponible en: http://www.eurekaselect.com/174648/article. Disponible en: 10.2174/1570159X17666190903103923.
Di Marzo, Vincenzo; Piscitelli, Fabiana (2015) The Endocannabinoid System and its Modulation by Phytocannabinoids. En: Neurotherapeutics. Vol. 12; No. 4; pp. 692-698; 1933-7213, 1878-7479; Consultado en: 2021/02/11/23:03:15. Disponible en: http://link.springer.com/10.1007/s13311-015-0374-6. Disponible en: 10.1007/s13311-015-0374-6.
Cristino, Luigia; Bisogno, Tiziana; Di Marzo, Vincenzo (2020) Cannabinoids and the expanded endocannabinoid system in neurological disorders. En: Nature Reviews Neurology. Vol. 16; No. 1; pp. 9-29; 1759-4758, 1759-4766; Consultado en: 2021/02/11/23:13:57. Disponible en: http://www.nature.com/articles/s41582-019-0284-z. Disponible en: 10.1038/s41582-019-0284-z.
Hu, Sherry Shu-Jung; Mackie, Ken; Pertwee, Roger G. (2015) Distribution of the Endocannabinoid System in the Central Nervous System. En: Endocannabinoids. Vol. 231; pp. 59-93; Cham: Springer International Publishing; 978-3-319-20824-4 978-3-319-20825-1; Consultado en: 2021/02/11/23:15:17. Disponible en: http://link.springer.com/10.1007/978-3-319-20825-1_3.
Kaur, Ishnoor; Behl, Tapan; Bungau, Simona; Zengin, Gokhan; Kumar, Arun; El-Esawi, Mohamed A.; Khullar, Gaurav; Venkatachalam, Thangavel; Arora, Sandeep (2020) The endocannabinoid signaling pathway as an emerging target in pharmacotherapy, earmarking mitigation of destructive events in rheumatoid arthritis. En: Life Sciences. Vol. 257; pp. 118109 00243205; Consultado en: 2021/02/11/23:19:41. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0024320520308602. Disponible en: 10.1016/j.lfs.2020.118109.
Shenglong Zou; Ujendra Kumar (2018) Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. En: International Journal of Molecular Sciences. Vol. 19; No. 3; pp. 833 1422-0067; Consultado en: 2021/02/11/23:38:34. Disponible en: http://www.mdpi.com/1422-0067/19/3/833. Disponible en: 10.3390/ijms19030833.
Maccarrone, Mauro; Bab, Itai; Bíró, Tamás; Cabral, Guy A.; Dey, Sudhansu K.; Di Marzo, Vincenzo; Konje, Justin C.; Kunos, George; Mechoulam, Raphael; Pacher, Pal; Sharkey, Keith A.; Zimmer, Andreas (2015) Endocannabinoid signaling at the periphery: 50 years after THC. En: Trends in Pharmacological Sciences. Vol. 36; No. 5; pp. 277-296; 01656147; Consultado en: 2021/02/11/23:47:39. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0165614715000346. Disponible en: 10.1016/j.tips.2015.02.008.
Prospéro-García, Oscar; Ruiz Contreras, Alejandra E.; Ortega Gómez, Alette; Herrera-Solís, Andrea; Méndez-Díaz, Mónica (2019) Endocannabinoids as Therapeutic Targets. En: Archives of Medical Research. Vol. 50; No. 8; pp. 518-526; 01884409; Consultado en: 2021/02/11/23:48:06. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0188440919304746. Disponible en: 10.1016/j.arcmed.2019.09.005.
ElSohly, Mahmoud A.; Slade, Desmond (2005) Chemical constituents of marijuana: The complex mixture of natural cannabinoids. En: Life Sciences. Vol. 78; No. 5; pp. 539-548; 00243205; Consultado en: 2021/02/17/01:08:42. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S002432050500891X. Disponible en: 10.1016/j.lfs.2005.09.011.
Booth, Judith K.; Bohlmann, Jörg (2019) Terpenes in Cannabis sativa – From plant genome to humans. En: Plant Science. Vol. 284; pp. 67-72; 01689452; Consultado en: 2021/02/17/02:09:42. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0168945219301190. Disponible en: 10.1016/j.plantsci.2019.03.022.
Gallily, Ruth; Yekhtin, Zhannah; Hanuš, Lumír Ondřej (2015) Overcoming the Bell-Shaped Dose-Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol. En: Pharmacology & Pharmacy. Vol. 06; No. 02; pp. 75-85; 2157-9423, 2157-9431; Consultado en: 2021/03/21/23:20:09. Disponible en: http://www.scirp.org/journal/doi.aspx?DOI=10.4236/pp.2015.62010. Disponible en: 10.4236/pp.2015.62010.
Sousa, Cátia; Leitão, Alcino Jorge; Neves, Bruno Miguel; Judas, Fernando; Cavaleiro, Carlos; Mendes, Alexandrina Ferreira (2020) Standardised comparison of limonene-derived monoterpenes identifies structural determinants of anti-inflammatory activity. En: Scientific Reports. Vol. 10; No. 1; pp. 7199 2045-2322; Consultado en: 2021/04/02/21:23:19. Disponible en: http://www.nature.com/articles/s41598-020-64032-1. Disponible en: 10.1038/s41598-020-64032-1.
Fukuda, Shin; Kohsaka, Hitoshi; Takayasu, Aiko; Yokoyama, Waka; Miyabe, Chie; Miyabe, Yoshishige; Harigai, Masayoshi; Miyasaka, Nobuyuki; Nanki, Toshihiro (2014) Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis. En: BMC Musculoskeletal Disorders. Vol. 15; No. 1; pp. 275 1471-2474; Consultado en: 2021/04/02/22:03:25. Disponible en: http://bmcmusculoskeletdisord.biomedcentral.com/articles/10.1186/1471-2474-15-275. Disponible en: 10.1186/1471-2474-15-275.
Almogi-Hazan, Osnat; Or, Reuven (2020) Cannabis, the Endocannabinoid System and Immunity—the Journey from the Bedside to the Bench and Back. En: International Journal of Molecular Sciences. Vol. 21; No. 12; pp. 4448 1422-0067; Consultado en: 2021/04/02/22:30:18. Disponible en: https://www.mdpi.com/1422-0067/21/12/4448. Disponible en: 10.3390/ijms21124448.
Ambrose, Tim; Simmons, Alison (2019) Cannabis, Cannabinoids, and the Endocannabinoid System—Is there Therapeutic Potential for Inflammatory Bowel Disease?. En: Journal of Crohn's and Colitis. Vol. 13; No. 4; pp. 525-535; 1873-9946, 1876-4479; Consultado en: 2021/04/02/22:34:02. Disponible en: https://academic.oup.com/ecco-jcc/article/13/4/525/5173479. Disponible en: 10.1093/ecco-jcc/jjy185.
Alves, Vera L.; Gonçalves, João L.; Aguiar, Joselin; Teixeira, Helena M.; Câmara, José S. (2020) The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review. En: Critical Reviews in Toxicology. Vol. 50; No. 5; pp. 359-382; 1040-8444, 1547-6898; Consultado en: 2021/04/13/05:28:38. Disponible en: https://www.tandfonline.com/doi/full/10.1080/10408444.2020.1762539. Disponible en: 10.1080/10408444.2020.1762539.
Pacher, Pál; Kunos, George (2013) Modulating the endocannabinoid system in human health and disease. En: FEBS Journal. Vol. 280; No. 9; pp. 1918-1943; 1742464X; Consultado en: 2021/04/14/22:25:47. Disponible en: http://doi.wiley.com/10.1111/febs.12260. Disponible en: 10.1111/febs.12260.
Straus, Daniel S.; Glass, Christopher K. (2007) Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. En: Trends in Immunology. Vol. 28; No. 12; pp. 551-558; 14714906; Consultado en: 2021/05/26/05:50:25. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S147149060700244X. Disponible en: 10.1016/j.it.2007.09.003.
Blasco-Benito, Sandra; Seijo-Vila, Marta; Caro-Villalobos, Miriam; Tundidor, Isabel; Andradas, Clara; García-Taboada, Elena; Wade, Jeff; Smith, Stewart; Guzmán, Manuel; Pérez-Gómez, Eduardo; Gordon, Mara; Sánchez, Cristina (2018) Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer. En: Biochemical Pharmacology. Vol. 157; pp. 285-293; 00062952; Consultado en: 2021/05/26/20:27:59. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0006295218302387. Disponible en: 10.1016/j.bcp.2018.06.025.
Kinghorn, A. Douglas; Falk, Heinz; Gibbons, Simon; Kobayashi, Jun'ichi (2017) Phytocannabinoids: Unraveling the Complex Chemistry and Pharmacology of Cannabis sativa. En: Progress in the Chemistry of Organic Natural Products. Vol. 103; Cham: Springer International Publishing; 978-3-319-45539-6 978-3-319-45541-9; Consultado en: 2021/09/28/16:59:11. Disponible en: http://link.springer.com/10.1007/978-3-319-45541-9.
Clayton, Paul; Hill, Mariko; Bogoda, Nathasha; Subah, Silma; Venkatesh, Ruchitha (2021) Palmitoylethanolamide: A Natural Compound for Health Management. En: International Journal of Molecular Sciences. Vol. 22; No. 10; pp. 5305 1422-0067; Consultado en: 2022/03/08/15:57:16. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157570/. Disponible en: 10.3390/ijms22105305.
Beggiato, Sarah; Tomasini, Maria Cristina; Ferraro, Luca (2019) Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer’s Disease. En: Frontiers in Pharmacology. Vol. 10; pp. 821 1663-9812; Consultado en: 2022/03/17/16:36:58. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667638/. Disponible en: 10.3389/fphar.2019.00821.
Colizzi, Marco; Bortoletto, Riccardo; Costa, Rosalia; Zoccante, Leonardo (2021) Palmitoylethanolamide and Its Biobehavioral Correlates in Autism Spectrum Disorder: A Systematic Review of Human and Animal Evidence. En: Nutrients. Vol. 13; No. 4; pp. 1346 2072-6643; Consultado en: 2022/03/17/16:37:13. Disponible en: https://www.mdpi.com/2072-6643/13/4/1346. Disponible en: 10.3390/nu13041346.
Depression. Consultado en: 2022/04/04/. Disponible en: https://www.who.int/health-topics/depression.
Babagi, Hisham Fawaz; Aljifri, Noor Mohammed M; Dali, Raghdah Suliman O; Jan, Salah M; Alqahtani, Lamya Mesfer; Abusrrah, Wael Mohammed; Alfaya, Abdullah; Alqurus, Zahra Ali M; Alswilem, Abdullah Mansour (2020) An overview on unipolar major depression in adults diagnosis and management approach. pp. 7
Ménard, C.; Hodes, G.E.; Russo, S.J. (2016) Pathogenesis of depression: Insights from human and rodent studies. En: Neuroscience. Vol. 321; pp. 138-162; 03064522; Consultado en: 2022/04/14/16:45:15. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0306452215004959. Disponible en: 10.1016/j.neuroscience.2015.05.053.
Pagano, Cristina; Navarra, Giovanna; Coppola, Laura; Avilia, Giorgio; Bifulco, Maurizio; Laezza, Chiara (2022) Cannabinoids: Therapeutic Use in Clinical Practice. En: International Journal of Molecular Sciences. Vol. 23; No. 6; pp. 3344 1422-0067; Consultado en: 2022/04/15/15:40:25. Disponible en: https://www.mdpi.com/1422-0067/23/6/3344. Disponible en: 10.3390/ijms23063344.
Fernández-Ruiz, Javier; Galve-Roperh, Ismael; Sagredo, Onintza; Guzmán, Manuel (2020) Possible therapeutic applications of cannabis in the neuropsychopharmacology field. En: European Neuropsychopharmacology. Vol. 36; pp. 217-234; 0924977X; Consultado en: 2022/04/15/15:43:03. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0924977X20300365. Disponible en: 10.1016/j.euroneuro.2020.01.013.
Poleszak, Ewa; Wośko, Sylwia; Sławińska, Karolina; Szopa, Aleksandra; Wróbel, Andrzej; Serefko, Anna (2018) Cannabinoids in depressive disorders. En: Life Sciences. Vol. 213; pp. 18-24; 00243205; Consultado en: 2022/04/15/15:43:48. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0024320518306040. Disponible en: 10.1016/j.lfs.2018.09.058.
Chadwick, Verity L.; Rohleder, Cathrin; Koethe, Dagmar; Leweke, F. Markus (2020) Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans. En: Current Opinion in Psychiatry. Vol. 33; No. 1; pp. 20-42; 0951-7367; Consultado en: 2022/04/15/15:49:17. Disponible en: https://journals.lww.com/10.1097/YCO.0000000000000562. Disponible en: 10.1097/YCO.0000000000000562.
Corroon, Jamie; Felice, Jake F (2019) The Endocannabinoid System and its Modulation by Cannabidiol (CBD). En: Alternative Therapies in Health & Medicine. Vol. 25; 1078-6791
Bilge, Serap; Ekici, Barış (2021) CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature. En: Journal of Cannabis Research. Vol. 3; No. 1; pp. 53 2522-5782; Consultado en: 2022/04/16/23:07:13. Disponible en: https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-021-00108-7. Disponible en: 10.1186/s42238-021-00108-7.
Anand, Uma; Pacchetti, Barbara; Anand, Praveen; Sodergren, Mikael Hans (2021) Cannabis-based medicines and pain: a review of potential synergistic and entourage effects. En: Pain Management. Vol. 11; No. 4; pp. 395-403; 1758-1869, 1758-1877; Consultado en: 2022/04/16/23:13:50. Disponible en: https://www.futuremedicine.com/doi/10.2217/pmt-2020-0110. Disponible en: 10.2217/pmt-2020-0110.
Di Giacomo, Silvia; Mariano, Alessia; Gullì, Marco; Fraschetti, Caterina; Vitalone, Annabella; Filippi, Antonello; Mannina, Luisa; Scotto d’Abusco, Anna; Di Sotto, Antonella (2021) Role of Caryophyllane Sesquiterpenes in the Entourage Effect of Felina 32 Hemp Inflorescence Phytocomplex in Triple Negative MDA-MB-468 Breast Cancer Cells. En: Molecules. Vol. 26; No. 21; pp. 6688 1420-3049; Consultado en: 2022/04/17/01:13:20. Disponible en: https://www.mdpi.com/1420-3049/26/21/6688. Disponible en: 10.3390/molecules26216688.
LaVigne, Justin E.; Hecksel, Ryan; Keresztes, Attila; Streicher, John M. (2021) Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity. En: Scientific Reports. Vol. 11; No. 1; pp. 8232 2045-2322; Consultado en: 2022/04/17/04:19:57. Disponible en: http://www.nature.com/articles/s41598-021-87740-8. Disponible en: 10.1038/s41598-021-87740-8.
Bautista, Johanna L.; Yu, Shu; Tian, Li (2021) Flavonoids in Cannabis sativa: Biosynthesis, Bioactivities, and Biotechnology. En: ACS Omega. Vol. 6; No. 8; pp. 5119-5123; 2470-1343, 2470-1343; Consultado en: 2022/04/17/04:23:56. Disponible en: https://pubs.acs.org/doi/10.1021/acsomega.1c00318. Disponible en: 10.1021/acsomega.1c00318.
Clayton, Paul; Subah, Silma; Venkatesh, Ruchitha; Hill, Mariko; Bogoda, Nathasha (2021) Palmitoylethanolamide: A Potential Alternative to Cannabidiol. En: Journal of Dietary Supplements. pp. 1-26; 1939-0211, 1939-022X; Consultado en: 2022/04/17/05:01:23. Disponible en: https://www.tandfonline.com/doi/full/10.1080/19390211.2021.2005733. Disponible en: 10.1080/19390211.2021.2005733.
Rankin, Linda; Fowler, Christopher J. (2020) The Basal Pharmacology of Palmitoylethanolamide. En: International Journal of Molecular Sciences. Vol. 21; No. 21; pp. 7942 1422-0067; Consultado en: 2022/04/17/20:46:04. Disponible en: https://www.mdpi.com/1422-0067/21/21/7942. Disponible en: 10.3390/ijms21217942.
Nasri, Hamid; Baradaran, Azar; Shirzad, Hedayatollah; Rafieian‑Kopaei, Mahmoud (2014) New Concepts in Nutraceuticals as Alternative for Pharmaceuticals. En: International Journal of Preventive Medicine. Vol. 5; No. 12; pp. 13
Ghazizadeh-Hashemi, Maryam; Ghajar, Alireza; Shalbafan, Mohammad-Reza; Ghazizadeh-Hashemi, Fatemeh; Afarideh, Mohsen; Malekpour, Farzaneh; Ghaleiha, Ali; Ardebili, Mehrdad Eftekhar; Akhondzadeh, Shahin (2018) Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial. En: Journal of Affective Disorders. Vol. 232; pp. 127-133; 01650327; Consultado en: 2022/04/17/23:08:38. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0165032717324278. Disponible en: 10.1016/j.jad.2018.02.057.
Gaoni, Y.; Mechoulam, R. (1964) Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish. En: Journal of the American Chemical Society. Vol. 86; No. 8; pp. 1646-1647; 0002-7863, 1520-5126; Consultado en: 2022/04/19/15:06:08. Disponible en: https://pubs.acs.org/doi/abs/10.1021/ja01062a046. Disponible en: 10.1021/ja01062a046.
Devane, William A.; Hanuš, Lumir; Breuer, Aviva; Pertwee, Roger G.; Stevenson, Lesley A.; Griffin, Graeme; Gibson, Dan; Mandelbaum, Asher; Etinger, Alexander; Mechoulam, Raphael (1992) Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor. En: Science. Vol. 258; No. 5090; pp. 1946-1949; 0036-8075, 1095-9203; Consultado en: 2022/04/19/15:33:12. Disponible en: https://www.science.org/doi/10.1126/science.1470919. Disponible en: 10.1126/science.1470919.
Mechoulam, Raphael; Ben-Shabat, Shimon; Hanus, Lumir; Ligumsky, Moshe; Kaminski, Norbert E.; Schatz, Anthony R.; Gopher, Asher; Almog, Shlomo; Martin, Billy R.; Compton, David R.; Pertwee, Roger G.; Griffin, Graeme; Bayewitch, Michael; Barg, Jacob; Vogel, Zvi (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. En: Biochemical Pharmacology. Vol. 50; No. 1; pp. 83-90; 00062952; Consultado en: 2022/04/19/15:37:31. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/000629529500109D. Disponible en: 10.1016/0006-2952(95)00109-D.
Matsuda, Lisa A; Lolait, Stephen J; Brownstein, Michael J; Young, Alice C; Bonner, Tom I (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. En: Nature. Vol. 346; No. 6284; pp. 561-564; 1476-4687; Disponible en: 10.1038/346561a0.
Munro, Sean; Thomas, Kerrie L; Abu-Shaar, Muna (1993) Molecular characterization of a peripheral receptor for cannabinoids. En: Nature. Vol. 365; No. 6441; pp. 61-65; 1476-4687; Disponible en: 10.1038/365061a0.
Centonze, Diego; Finazzi-Agro, Alessandro; Bernardi, Giorgio; Maccarrone, Mauro (2007) The endocannabinoid system in targeting inflammatory neurodegenerative diseases. En: Trends in pharmacological sciences. Vol. 28; No. 4; pp. 180-187; 0165-6147; Disponible en: 10.1016/j.tips.2007.02.004.
Skaper, Stephen D; Di Marzo, Vincenzo (2012) Endocannabinoids in nervous system health and disease: the big picture in a nutshell. En: Philosophical Transactions of the Royal Society B: Biological Sciences. Vol. 367; No. 1607; pp. 3193-3200; 0962-8436; Disponible en: 10.1098/rstb.2012.0313.
Klein, Thomas W (2005) Cannabinoid-based drugs as anti-inflammatory therapeutics. En: Nature Reviews Immunology. Vol. 5; No. 5; pp. 400-411; 1474-1741; Disponible en: 10.1038/nri1602.
Pacher, Pál; Mukhopadhyay, Partha; Mohanraj, Rajesh; Godlewski, Grzegorz; Bátkai, Sándor; Kunos, George (2008) Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations. En: Hypertension. Vol. 52; No. 4; pp. 601-607; 0194-911X; Disponible en: 10.1161/HYPERTENSIONAHA.105.063651.
Guindon, Josée; Hohmann, Andrea G (2009) The endocannabinoid system and pain. En: CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders). Vol. 8; No. 6; pp. 403-421; 1871-5273; Disponible en: 10.2174/187152709789824660.
Velasco, Guillermo; Sánchez, Cristina; Guzmán, Manuel (2012) Towards the use of cannabinoids as antitumour agents. En: Nature Reviews Cancer. Vol. 12; No. 6; pp. 436-444; 1474-1768; Disponible en: 10.1038/nrc3247.
Huang, Wen-Juan; Chen, Wei-Wei; Zhang, Xia (2016) Endocannabinoid system: Role in depression, reward and pain control (Review). En: Molecular Medicine Reports. Vol. 14; No. 4; pp. 2899-2903; 1791-2997, 1791-3004; Consultado en: 2022/04/23/03:07:30. Disponible en: https://www.spandidos-publications.com/10.3892/mmr.2016.5585. Disponible en: 10.3892/mmr.2016.5585.
Lowe, Henry; Toyang, Ngeh; Steele, Blair; Bryant, Joseph; Ngwa, Wilfred (2021) The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases. En: International Journal of Molecular Sciences. Vol. 22; No. 17; pp. 9472 1422-0067; Consultado en: 2022/04/23/03:11:57. Disponible en: https://www.mdpi.com/1422-0067/22/17/9472. Disponible en: 10.3390/ijms22179472.
Navarrete, Francisco; García-Gutiérrez, María Salud; Jurado-Barba, Rosa; Rubio, Gabriel; Gasparyan, Ani; Austrich-Olivares, Amaya; Manzanares, Jorge (2020) Endocannabinoid System Components as Potential Biomarkers in Psychiatry. En: Frontiers in Psychiatry. Vol. 11; pp. 315 1664-0640; Consultado en: 2022/04/23/03:13:43. Disponible en: https://www.frontiersin.org/article/10.3389/fpsyt.2020.00315/full. Disponible en: 10.3389/fpsyt.2020.00315.
Zádor, Ferenc; Joca, Sâmia; Nagy-Grócz, Gábor; Dvorácskó, Szabolcs; Szűcs, Edina; Tömböly, Csaba; Benyhe, Sándor; Vécsei, László (2021) Pro-Inflammatory Cytokines: Potential Links between the Endocannabinoid System and the Kynurenine Pathway in Depression. En: International Journal of Molecular Sciences. Vol. 22; No. 11; pp. 5903 1422-0067; Consultado en: 2022/04/23/03:16:31. Disponible en: https://www.mdpi.com/1422-0067/22/11/5903. Disponible en: 10.3390/ijms22115903.
Graczyk, Michał; Łukowicz, Małgorzata; Dzierzanowski, Tomasz (2021) Prospects for the Use of Cannabinoids in Psychiatric Disorders. En: Frontiers in Psychiatry. Vol. 12; pp. 620073 1664-0640; Consultado en: 2022/04/23/03:20:25. Disponible en: https://www.frontiersin.org/articles/10.3389/fpsyt.2021.620073/full. Disponible en: 10.3389/fpsyt.2021.620073.
Kasatkina, Ludmila A.; Rittchen, Sonja; Sturm, Eva M. (2021) Neuroprotective and Immunomodulatory Action of the Endocannabinoid System under Neuroinflammation. En: International Journal of Molecular Sciences. Vol. 22; No. 11; pp. 5431 1422-0067; Consultado en: 2022/04/23/03:20:36. Disponible en: https://www.mdpi.com/1422-0067/22/11/5431. Disponible en: 10.3390/ijms22115431.
Smaga, Irena; Bystrowska, Beata; Gawlinski, Dawid; Przegalinski, Edmund; Filip, Malgorzata (2014) The Endocannabinoid/Endovanilloid System and Depression. En: Current Neuropharmacology. Vol. 12; No. 5; pp. 462-474; 1570159X; Consultado en: 2022/04/23/03:21:01. Disponible en: http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1570-159X&volume=12&issue=5&spage=462. Disponible en: 10.2174/1570159X12666140923205412.
Garani, Ranjini; Watts, Jeremy J.; Mizrahi, Romina (2021) Endocannabinoid system in psychotic and mood disorders, a review of human studies. En: Progress in Neuro-Psychopharmacology and Biological Psychiatry. Vol. 106; pp. 110096 02785846; Consultado en: 2022/04/23/03:21:53. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0278584620304127. Disponible en: 10.1016/j.pnpbp.2020.110096.
Yarar, Erhan (2020) Role and Function of Endocannabinoid System in Major Depressive Disease. En: Medical Cannabis and Cannabinoids. Vol. 4; No. 1; pp. 1-12; 2504-3889; Consultado en: 2022/04/23/03:23:06. Disponible en: https://www.karger.com/Article/FullText/511979. Disponible en: 10.1159/000511979.
Rana, Tarapati; Behl, Tapan; Sehgal, Aayush; Mehta, Vineet; Singh, Sukhbir; Kumar, Ravinder; Bungau, Simona (2021) Integrating Endocannabinoid Signalling In Depression. En: Journal of Molecular Neuroscience. Vol. 71; No. 10; pp. 2022-2034; 0895-8696, 1559-1166; Consultado en: 2022/04/23/03:24:41. Disponible en: https://link.springer.com/10.1007/s12031-020-01774-7. Disponible en: 10.1007/s12031-020-01774-7.
Pariante, Carmine M; Why are depressed patients inflamed? A reflection on 20 years of research on depression, glucocorticoid resistance and inflammation. pp. 6 Disponible en: 10.1016/j.euroneuro.2017.04.001.
Anisman, H; Merali, Z (2002) Cytokines, stress, and depressive illness. pp. 12 Disponible en: 10.1016/s0889-1591(02)00009-0.
Adamczyk, P; Golda, A; McCreary, AC; Filip, M; Przegaliriski, E (2008) Activation of endocannabinoid transmission induces antidepressant-like effects in rats. En: Acta physiologica Polonica. Vol. 59; No. 2; pp. 217 0044-6033
Umathe, Sudhir N; Manna, Shyamshree SS; Jain, Nishant S (2011) Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice. En: Behavioural brain research. Vol. 223; No. 1; pp. 125-134; 0166-4328; Disponible en: 10.1016/j.bbr.2011.04.031.
Shearman, LP; Rosko, KM; Fleischer, R; Wang, J; Xu, S; Tong, XS; Rocha, Beatriz A (2003) Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice. En: Behavioural pharmacology. Vol. 14; No. 8; pp. 573-582; 0955-8810; Disponible en: 10.1097/00008877-200312000-00001.
Tzavara, Eleni T; Davis, Richard J; Perry, Kenneth W; Li, Xia; Salhoff, Craig; Bymaster, Frank P; Witkin, Jeffrey M; Nomikos, George G (2003) The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions. En: British journal of pharmacology. Vol. 138; No. 4; pp. 544-553; 0007-1188; Disponible en: 10.1038/sj.bjp.0705100.
Petrosino, Stefania; Di Marzo, Vincenzo (2017) The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations. En: British Journal of Pharmacology. Vol. 174; No. 11; pp. 1349-1365; 00071188; Consultado en: 2022/04/26/15:48:54. Disponible en: https://onlinelibrary.wiley.com/doi/10.1111/bph.13580. Disponible en: 10.1111/bph.13580.
Okamoto, Yasuo; Morishita, Jun; Tsuboi, Kazuhito; Tonai, Takeharu; Ueda, Natsuo (2004) Molecular characterization of a phospholipase D generating anandamide and its congeners. En: Journal of Biological Chemistry. Vol. 279; No. 7; pp. 5298-5305; 0021-9258; Disponible en: 10.1074/jbc.M306642200.
Ueda, Natsuo; Yamanaka, Kenji; Yamamoto, Shozo (2001) Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance. En: Journal of Biological Chemistry. Vol. 276; No. 38; pp. 35552-35557; 0021-9258; Disponible en: 10.1074/jbc.M106261200.
Bougarne, Nadia; Weyers, Basiel; Desmet, Sofie J; Deckers, Julie; Ray, David W; Staels, Bart; De Bosscher, Karolien (2018) Molecular actions of PPAR α in lipid metabolism and inflammation. En: Endocrine reviews. Vol. 39; No. 5; pp. 760-802; 0163-769X; Disponible en: 10.1210/er.2018-00064.
Lo Verme, Jesse; Fu, Jin; Astarita, Giuseppe; La Rana, Giovanna; Russo, Roberto; Calignano, Antonio; Piomelli, Daniele (2005) The Nuclear Receptor Peroxisome Proliferator-Activated Receptor-α Mediates the Anti-Inflammatory Actions of Palmitoylethanolamide. En: Molecular Pharmacology. Vol. 67; No. 1; pp. 15-19; 0026-895X, 1521-0111; Consultado en: 2022/04/28/17:27:18. Disponible en: http://molpharm.aspetjournals.org/lookup/doi/10.1124/mol.104.006353. Disponible en: 10.1124/mol.104.006353.
LoVerme, Jesse; La Rana, Giovanna; Russo, Roberto; Calignano, Antonio; Piomelli, Daniele (2005) The search for the palmitoylethanolamide receptor. En: Life Sciences. Vol. 77; No. 14; pp. 1685-1698; 00243205; Consultado en: 2022/04/28/17:28:28. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0024320505004911. Disponible en: 10.1016/j.lfs.2005.05.012.
Iannotti, Fabio Arturo; Vitale, Rosa Maria (2021) The Endocannabinoid System and PPARs: Focus on Their Signalling Crosstalk, Action and Transcriptional Regulation. En: Cells. Vol. 10; No. 3; pp. 586 2073-4409; Consultado en: 2022/04/28/19:52:30. Disponible en: https://www.mdpi.com/2073-4409/10/3/586. Disponible en: 10.3390/cells10030586.
Esposito, Emanuela; Cuzzocrea, Salvatore (2013) Palmitoylethanolamide in homeostatic and traumatic central nervous system injuries. En: CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders). Vol. 12; No. 1; pp. 55-61; 1871-5273; Disponible en: 10.2174/1871527311312010010.
Cordaro, Marika; Impellizzeri, Daniela; Paterniti, Irene; Bruschetta, Giuseppe; Siracusa, Rosalba; De Stefano, Daniela; Cuzzocrea, Salvatore; Esposito, Emanuela (2016) Neuroprotective effects of Co-ultraPEALut on secondary inflammatory process and autophagy involved in traumatic brain injury. En: Journal of neurotrauma. Vol. 33; No. 1; pp. 132-146; 0897-7151; Disponible en: 10.1089/neu.2014.3460.
Cruzblanca, Humberto; Lupercio, Patricia; Collas, Jorge; Castro, Elena; Centro Universitario de Investigaciones Biomédicas, Universidad de Colima, Colima, Col., México. (2016) Neurobiología de la depresión mayor y de su tratamiento farmacológico. En: Salud mental. Vol. 39; No. 1; pp. 47-58; 0185-3325; Consultado en: 2022/05/04/23:53:18. Disponible en: http://revistasaludmental.mx/index.php/salud_mental/article/view/SM.0185-3325.2015.067. Disponible en: 10.17711/SM.0185-3325.2015.067.
Beurel, Eléonore; Toups, Marisa; Nemeroff, Charles B. (2020) The Bidirectional Relationship of Depression and Inflammation: Double Trouble. En: Neuron. Vol. 107; No. 2; pp. 234-256; 08966273; Consultado en: 2022/05/05/00:58:32. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0896627320304311. Disponible en: 10.1016/j.neuron.2020.06.002.
Andre, Christelle M; Hausman, Jean-Francois; Guerriero, Gea (2016) Cannabis sativa: the plant of the thousand and one molecules. En: Frontiers in plant science. Vol. 7; pp. 19 1664-462X; Disponible en: 10.3389/fpls.2016.00019.
Wasserman, Danuta (2011) Depression. : OUP Oxford; 0-19-163151-5
Li, Gang; Zhang, Ling; DiBernardo, Allitia; Wang, Grace; Sheehan, John J.; Lee, Kwan; Reutfors, Johan; Zhang, Qiaoyi; Wilson, Fernando A. (2020) A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients. En: PLOS ONE. Vol. 15; No. 9; pp. e0238843 1932-6203; Consultado en: 2022/06/16/22:20:57. Disponible en: https://dx.plos.org/10.1371/journal.pone.0238843. Disponible en: 10.1371/journal.pone.0238843.
Kennedy, Sidney H; Lam, Raymond W; Nutt, David J; Thase, Michael (2004) Treating depression effectively. : SciELO Espana; 1-84184-328-8
Burstein, Sumner H.; Zurier, Robert B. (2009) Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation. En: The AAPS Journal. Vol. 11; No. 1; pp. 109 1550-7416; Consultado en: 2022/07/23/04:14:35. Disponible en: http://link.springer.com/10.1208/s12248-009-9084-5. Disponible en: 10.1208/s12248-009-9084-5.
Ministerio de Salud y Protección Social de Colombia (2017) Boletín de salud mental: Depresión. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/ENT/boletin-depresion-marzo-2017.pdf.
Departamento Administrativo Nacional De Estadística (2021) Salud mental en Colombia: Un análisis de los efectos de la pandemia. Disponible en: https://ascofapsi.org.co/pdf/Noticias/Estad%C3%ADstica%20de%20Salud%20mental%20en%20Colombia-%20pandemia%202021%20.pdf.
Rice, Frances (2010) Genetics of childhood and adolescent depression: insights into etiological heterogeneity and challenges for future genomic research. En: Genome Medicine. Vol. 2; No. 9; pp. 68 1756-994X; Consultado en: 2022/07/23/07:09:48. Disponible en: http://genomemedicine.biomedcentral.com/articles/10.1186/gm189. Disponible en: 10.1186/gm189.
Holmans, Peter; Zubenko, George S.; Crowe, Raymond R.; DePaulo, J. Raymond; Scheftner, William A.; Weissman, Myrna M.; Zubenko, Wendy N.; Boutelle, Sandra; Murphy-Eberenz, Kathleen; MacKinnon, Dean; McInnis, Melvin G.; Marta, Diana H.; Adams, Philip; Knowles, James A.; Gladis, Madeleine; Thomas, Jo; Chellis, Jennifer; Miller, Erin; Levinson, Douglas F. (2004) Genomewide Significant Linkage to Recurrent, Early-Onset Major Depressive Disorder on Chromosome 15q. En: The American Journal of Human Genetics. Vol. 74; No. 6; pp. 1154-1167; 00029297; Consultado en: 2022/07/23/07:11:48. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0002929707628420. Disponible en: 10.1086/421333.
Abkevich, Victor; Camp, Nicola J.; Hensel, Charles H.; Neff, Chris D.; Russell, Deanna L.; Hughes, Dana C.; Plenk, Agnes M.; Lowry, Michael R.; Richards, R. Lynn; Carter, Catherine; Frech, Georges C.; Stone, Steven; Rowe, Kerry; Chau, Chi Ai; Cortado, Kathleen; Hunt, Angelene; Luce, Karanina; O’Neil, Gayanne; Poarch, Jeff; Potter, Jennifer; Poulsen, Gregg H.; Saxton, Heidi; Bernat-Sestak, Michelle; Thompson, Victor; Gutin, Alexander; Skolnick, Mark H.; Shattuck, Donna; Cannon-Albright, Lisa (2003) Predisposition Locus for Major Depression at Chromosome 12q22-12q23.2. En: The American Journal of Human Genetics. Vol. 73; No. 6; pp. 1271-1281; 00029297; Consultado en: 2022/07/23/07:12:38. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0002929707639809. Disponible en: 10.1086/379978.
Yamada, Kazuo; Hattori, Eiji; Iwayama, Yoshimi; Ohnishi, Tetsuo; Ohba, Hisako; Toyota, Tomoko; Takao, Hitomi; Minabe, Yoshio; Nakatani, Noriaki; Higuchi, Teruhiko; Detera-Wadleigh, Sevilla D.; Yoshikawa, Takeo (2006) Distinguishable Haplotype Blocks in the HTR3A and HTR3B Region in the Japanese Reveal Evidence of Association of HTR3B with Female Major Depression. En: Biological Psychiatry. Vol. 60; No. 2; pp. 192-201; 00063223; Consultado en: 2022/07/23/07:14:22. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0006322305013983. Disponible en: 10.1016/j.biopsych.2005.11.008.
Binder, Elisabeth B; Salyakina, Daria; Lichtner, Peter; Wochnik, Gabriele M; Ising, Marcus; Pütz, Benno; Papiol, Sergi; Seaman, Shaun; Lucae, Susanne; Kohli, Martin A; Nickel, Thomas; Künzel, Heike E; Fuchs, Brigitte; Majer, Matthias; Pfennig, Andrea; Kern, Nikola; Brunner, Jürgen; Modell, Sieglinde; Baghai, Thomas; Deiml, Tobias; Zill, Peter; Bondy, Brigitta; Rupprecht, Rainer; Messer, Thomas; Köhnlein, Oliver; Dabitz, Heike; Brückl, Tanja; Müller, Nina; Pfister, Hildegard; Lieb, Roselind; Mueller, Jakob C; Lõhmussaar, Elin; Strom, Tim M; Bettecken, Thomas; Meitinger, Thomas; Uhr, Manfred; Rein, Theo; Holsboer, Florian; Muller-Myhsok, Bertram (2004) Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. En: Nature Genetics. Vol. 36; No. 12; pp. 1319-1325; 1061-4036, 1546-1718; Consultado en: 2022/07/23/07:15:47. Disponible en: http://www.nature.com/articles/ng1479. Disponible en: 10.1038/ng1479.
Uhr, Manfred; Tontsch, Alina; Namendorf, Christian; Ripke, Stephan; Lucae, Susanne; Ising, Marcus; Dose, Tatjana; Ebinger, Martin; Rosenhagen, Marcus; Kohli, Martin; Kloiber, Stefan; Salyakina, Daria; Bettecken, Thomas; Specht, Michael; Pütz, Benno; Binder, Elisabeth B.; Müller-Myhsok, Bertram; Holsboer, Florian (2008) Polymorphisms in the Drug Transporter Gene ABCB1 Predict Antidepressant Treatment Response in Depression. En: Neuron. Vol. 57; No. 2; pp. 203-209; 08966273; Consultado en: 2022/07/23/07:17:23. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0896627307009750. Disponible en: 10.1016/j.neuron.2007.11.017.
Bishop, Jeffrey R; Moline, Jessica; Ellingrod, Vicki L; Schultz, Susan K; Clayton, Anita H (2006) Serotonin 2A −1438 G/A and G-Protein Beta3 Subunit C825T Polymorphisms in Patients with Depression and SSRI-Associated Sexual Side-Effects. En: Neuropsychopharmacology. Vol. 31; No. 10; pp. 2281-2288; 0893-133X, 1740-634X; Consultado en: 2022/07/23/07:17:49. Disponible en: http://www.nature.com/articles/1301090. Disponible en: 10.1038/sj.npp.1301090.
Bruce, Martha L (2002) Psychosocial risk factors for depressive disorders in late life. En: Biological Psychiatry. Vol. 52; No. 3; pp. 175-184; 00063223; Consultado en: 2022/07/23/07:19:43. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0006322302014105. Disponible en: 10.1016/S0006-3223(02)01410-5.
Frodl, Thomas; Reinhold, Elena; Koutsouleris, Nikolaos; Donohoe, Gary; Bondy, Brigitta; Reiser, Maximilian; Möller, Hans-Jürgen; Meisenzahl, Eva M (2010) Childhood Stress, Serotonin Transporter Gene and Brain Structures in Major Depression. En: Neuropsychopharmacology. Vol. 35; No. 6; pp. 1383-1390; 0893-133X, 1740-634X; Consultado en: 2022/07/23/07:23:04. Disponible en: http://www.nature.com/articles/npp20108. Disponible en: 10.1038/npp.2010.8.
Karg, Katja; Burmeister, Margit; Shedden, Kerby; Sen, Srijan (2011) The Serotonin Transporter Promoter Variant (5-HTTLPR), Stress, and Depression Meta-analysis Revisited: Evidence of Genetic Moderation. En: Archives of General Psychiatry. Vol. 68; No. 5; pp. 444 0003-990X; Consultado en: 2022/07/23/07:24:03. Disponible en: http://archpsyc.jamanetwork.com/article.aspx?doi=10.1001/archgenpsychiatry.2010.189. Disponible en: 10.1001/archgenpsychiatry.2010.189.
Edition, Fifth (2013) Diagnostic and statistical manual of mental disorders. En: Am Psychiatric Assoc. Vol. 21; No. 21; pp. 591-643
Manual MSD versión para profesionales; Trastornos depresivos. Disponible en: https://www.msdmanuals.com/es/professional/trastornos-psiquiátricos/trastornos-del-estado-de-ánimo/trastornos-depresivos.
Siegmann, Eva-Maria; Müller, Helge H. O.; Luecke, Caroline; Philipsen, Alexandra; Kornhuber, Johannes; Grömer, Teja Wolfgang (2018) Association of Depression and Anxiety Disorders With Autoimmune Thyroiditis: A Systematic Review and Meta-analysis. En: JAMA Psychiatry. Vol. 75; No. 6; pp. 577 2168-622X; Consultado en: 2022/07/23/07:58:36. Disponible en: http://archpsyc.jamanetwork.com/article.aspx?doi=10.1001/jamapsychiatry.2018.0190. Disponible en: 10.1001/jamapsychiatry.2018.0190.
Ko, Dennis T. (2002) β-Blocker Therapy and Symptoms of Depression, Fatigue, and Sexual Dysfunction. En: JAMA. Vol. 288; No. 3; pp. 351 0098-7484; Consultado en: 2022/07/23/08:00:41. Disponible en: http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.288.3.351. Disponible en: 10.1001/jama.288.3.351.
Mele, Bria; Watt, Jennifer; Wu, Pauline; Azeem, Feeha; Lew, Grace; Holroyd–Leduc, Jayna; Goodarzi, Zahra (2022) Detecting depression in persons living in long-term care: a systematic review and meta-analysis of diagnostic test accuracy studies. En: Age and Ageing. Vol. 51; No. 3; pp. afac039 0002-0729, 1468-2834; Consultado en: 2022/07/23/08:03:58. Disponible en: https://academic.oup.com/ageing/article/doi/10.1093/ageing/afac039/6540127. Disponible en: 10.1093/ageing/afac039.
Chambless, Dianne L. (1993) Task Force on Promotion and Dissemination of Psychological Procedures: A Report Adopted by the Division 12 Board-October 1993: (550782009-001). : American Psychological Association; Consultado en: 2022/07/23/08:10:03. Disponible en: http://doi.apa.org/get-pe-doi.cfm?doi=10.1037/e550782009-001.
Chambless, Dianne L.; Hollon, Steven D. (1998) Defining empirically supported therapies. En: Journal of Consulting and Clinical Psychology. Vol. 66; No. 1; pp. 7-18; 1939-2117, 0022-006X; Consultado en: 2022/07/23/08:11:16. Disponible en: http://doi.apa.org/getdoi.cfm?doi=10.1037/0022-006X.66.1.7. Disponible en: 10.1037/0022-006X.66.1.7.
Hollon, Steven D.; Ponniah, Kathryn (2010) A review of empirically supported psychological therapies for mood disorders in adults. En: Depression and Anxiety. Vol. 27; No. 10; pp. 891-932; 10914269; Consultado en: 2022/07/23/08:15:11. Disponible en: https://onlinelibrary.wiley.com/doi/10.1002/da.20741. Disponible en: 10.1002/da.20741.
Miniati, Mario; Marzetti, Francesca; Palagini, Laura; Conversano, Ciro; Buccianelli, Beatrice; Marazziti, Donatella; Gemignani, Angelo (2021) Telephone-delivered Interpersonal Psychotherapy: a systematic review. En: CNS Spectrums. pp. 1-13; 1092-8529, 2165-6509; Consultado en: 2022/07/23/08:17:14. Disponible en: https://www.cambridge.org/core/product/identifier/S1092852921000948/type/journal_article. Disponible en: 10.1017/S1092852921000948.
Bernecker, Samantha L.; Coyne, Alice E.; Constantino, Michael J.; Ravitz, Paula (2017) For whom does interpersonal psychotherapy work? A systematic review. En: Clinical Psychology Review. Vol. 56; pp. 82-93; 02727358; Consultado en: 2022/07/23/08:18:51. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0272735817300120. Disponible en: 10.1016/j.cpr.2017.07.001.
Zhang, Anao; Borhneimer, Lindsay A.; Weaver, Addie; Franklin, Cynthia; Hai, Audrey Hang; Guz, Samantha; Shen, Li (2019) Cognitive behavioral therapy for primary care depression and anxiety: a secondary meta-analytic review using robust variance estimation in meta-regression. En: Journal of Behavioral Medicine. Vol. 42; No. 6; pp. 1117-1141; 0160-7715, 1573-3521; Consultado en: 2022/07/23/08:21:10. Disponible en: http://link.springer.com/10.1007/s10865-019-00046-z. Disponible en: 10.1007/s10865-019-00046-z.
Zhang, Anao; Franklin, Cynthia; Jing, Shijie; Bornheimer, Lindsay A.; Hai, Audrey Hang; Himle, Joseph A.; Kong, Dexia; Ji, Qingying (2019) The effectiveness of four empirically supported psychotherapies for primary care depression and anxiety: A systematic review and meta-analysis. En: Journal of Affective Disorders. Vol. 245; pp. 1168-1186; 01650327; Consultado en: 2022/07/23/08:23:34. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0165032718319608. Disponible en: 10.1016/j.jad.2018.12.008.
Nezu, Arthur M; Nezu, CM; D’zurilla, TJ (2007) Solving life’s problems. En: New York, US.
Hopko, Derek R.; Lejuez, C.W.; Ruggiero, Kenneth J.; Eifert, Georg H. (2003) Contemporary behavioral activation treatments for depression: Procedures, principles, and progress. En: Clinical Psychology Review. Vol. 23; No. 5; pp. 699-717; 02727358; Consultado en: 2022/07/23/08:27:07. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0272735803000709. Disponible en: 10.1016/S0272-7358(03)00070-9.
Cipriani, Andrea; Furukawa, Toshi A; Salanti, Georgia; Chaimani, Anna; Atkinson, Lauren Z; Ogawa, Yusuke; Leucht, Stefan; Ruhe, Henricus G; Turner, Erick H; Higgins, Julian P T; Egger, Matthias; Takeshima, Nozomi; Hayasaka, Yu; Imai, Hissei; Shinohara, Kiyomi; Tajika, Aran; Ioannidis, John P A; Geddes, John R (2018) Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis. En: FOCUS. Vol. 16; No. 4; pp. 420-429; 1541-4094, 1541-4108; Consultado en: 2022/07/23/08:29:07. Disponible en: https://psychiatryonline.org/doi/10.1176/appi.focus.16407. Disponible en: 10.1176/appi.focus.16407.
Pinquart, Martin; Duberstein, Paul R.; Lyness, Jeffrey M. (2006) Treatments for Later-Life Depressive Conditions: A Meta-Analytic Comparison of Pharmacotherapy and Psychotherapy. En: American Journal of Psychiatry. Vol. 163; No. 9; pp. 1493-1501; 0002-953X, 1535-7228; Consultado en: 2022/07/23/08:31:52. Disponible en: http://psychiatryonline.org/doi/abs/10.1176/ajp.2006.163.9.1493. Disponible en: 10.1176/ajp.2006.163.9.1493.
American Psychological Association (2019) Clinical practice guideline for the treatment of depression across three age cohorts. En: Washington, DC: Author.
Hetrick, Sarah E; McKenzie, Joanne E; Bailey, Alan P; Sharma, Vartika; Moller, Carl I; Badcock, Paul B; Cox, Georgina R; Merry, Sally N; Meader, Nicholas; Cochrane Common Mental Disorders Group (2021) New generation antidepressants for depression in children and adolescents: a network meta-analysis. En: Cochrane Database of Systematic Reviews. Vol. 2021; No. 5; 14651858; Consultado en: 2022/07/23/08:37:28. Disponible en: http://doi.wiley.com/10.1002/14651858.CD013674.pub2. Disponible en: 10.1002/14651858.CD013674.pub2.
Rush, A. John; Trivedi, Madhukar H.; Stewart, Jonathan W.; Nierenberg, Andrew A.; Fava, Maurizio; Kurian, Benji T.; Warden, Diane; Morris, David W.; Luther, James F.; Husain, Mustafa M.; Cook, Ian A.; Shelton, Richard C.; Lesser, Ira M.; Kornstein, Susan G.; Wisniewski, Stephen R. (2011) Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study. En: American Journal of Psychiatry. Vol. 168; No. 7; pp. 689-701; 0002-953X, 1535-7228; Consultado en: 2022/07/23/08:39:42. Disponible en: http://psychiatryonline.org/doi/abs/10.1176/appi.ajp.2011.10111645. Disponible en: 10.1176/appi.ajp.2011.10111645.
Canuso, Carla M.; Singh, Jaskaran B.; Fedgchin, Maggie; Alphs, Larry; Lane, Rosanne; Lim, Pilar; Pinter, Christine; Hough, David; Sanacora, Gerard; Manji, Husseini; Drevets, Wayne C. (2018) Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study. En: American Journal of Psychiatry. Vol. 175; No. 7; pp. 620-630; 0002-953X, 1535-7228; Consultado en: 2022/07/23/08:42:13. Disponible en: http://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2018.17060720. Disponible en: 10.1176/appi.ajp.2018.17060720.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Stott, Colin; Guy, Geoffrey (2004) Cannabinoids for the pharmaceutical industry. En: Euphytica. Vol. 140; No. 1/2; pp. 83-93; 00142336; Consultado en: 2020/07/05/04:32:13. Disponible en: http://ezproxy.javeriana.edu.co:2048/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=a9h&AN=16342632&lang=es&site=eds-live. Disponible en: 10.1007/s10681-004-4757-8.
Gonçalves, Elaine C. D.; Baldasso, Gabriela M.; Bicca, Maíra A.; Paes, Rodrigo S.; Capasso, Raffaele; Dutra, Rafael C.; McPhee, Derek J. (2020) Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant. En: Molecules. Vol. 25; No. 7; pp. 1567 14203049; Consultado en: 2020/07/08/05:32:11. Disponible en: http://ezproxy.javeriana.edu.co:2048/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=a9h&AN=142828348&lang=es&site=eds-live. Disponible en: 10.3390/molecules25071567.
Russo, Ethan B. (2011) Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. En: British Journal of Pharmacology. Vol. 163; No. 7; pp. 1344-1364; 1476-5381; Consultado en: 2020/07/16/05:35:13. Disponible en: https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1476-5381.2011.01238.x. Disponible en: 10.1111/j.1476-5381.2011.01238.x.
Guindon, Josée; Hohmann, Andrea G. (2011) The endocannabinoid system and cancer: therapeutic implication. En: British Journal of Pharmacology. Vol. 163; No. 7; pp. 1447-1463; 1476-5381; Consultado en: 2020/07/16/05:38:00. Disponible en: https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1476-5381.2011.01327.x. Disponible en: 10.1111/j.1476-5381.2011.01327.x.
Aizpurua-Olaizola, Oier; Elezgarai, Izaskun; Rico-Barrio, Irantzu; Zarandona, Iratxe; Etxebarria, Nestor; Usobiaga, Aresatz (2017) Targeting the endocannabinoid system: future therapeutic strategies. En: Drug Discovery Today. Vol. 22; No. 1; pp. 105-110; 13596446; Consultado en: 2020/08/09/04:33:03. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S1359644616302926. Disponible en: 10.1016/j.drudis.2016.08.005.
Russo, Ethan B. (2016) Beyond Cannabis: Plants and the Endocannabinoid System. En: Trends in Pharmacological Sciences. Vol. 37; No. 7; pp. 594-605; 01656147; Consultado en: 2020/09/13/04:39:37. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0165614716300165. Disponible en: 10.1016/j.tips.2016.04.005.
Mechoulam, Raphael; Parker, Linda A. (2013) The Endocannabinoid System and the Brain. En: Annual Review of Psychology. Vol. 64; No. 1; pp. 21-47; 0066-4308, 1545-2085; Consultado en: 2020/09/13/05:02:20. Disponible en: http://www.annualreviews.org/doi/10.1146/annurev-psych-113011-143739. Disponible en: 10.1146/annurev-psych-113011-143739.
Pacher, Pál; Bátkai, Sándor; Kunos, George (2006) The Endocannabinoid System as an Emerging Target of Pharmacotherapy. En: Pharmacological Reviews. Vol. 58; No. 3; pp. 389-462; 0031-6997, 1521-0081; Consultado en: 2020/10/06/03:18:57. Disponible en: http://pharmrev.aspetjournals.org/lookup/doi/10.1124/pr.58.3.2. Disponible en: 10.1124/pr.58.3.2.
Pertwee, Roger G (2014) Handbook of Cannabis. : Oxford University Press, USA; 0-19-966268-1
Bisogno, T; Ligresti, A; Dimarzo, V (2005) The endocannabinoid signalling system: Biochemical aspects. En: Pharmacology Biochemistry and Behavior. Vol. 81; No. 2; pp. 224-238; 00913057; Consultado en: 2021/02/05/15:56:51. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0091305705001383. Disponible en: 10.1016/j.pbb.2005.01.027.
Ferber, Sari Goldstein; Namdar, Dvora; Hen-Shoval, Danielle; Eger, Gilad; Koltai, Hinanit; Shoval, Gal; Shbiro, Liat; Weller, Aron (2020) The “Entourage Effect”: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders. En: Current Neuropharmacology. Vol. 18; No. 2; pp. 87-96; 1570159X; Consultado en: 2021/02/06/16:17:44. Disponible en: http://www.eurekaselect.com/174648/article. Disponible en: 10.2174/1570159X17666190903103923.
Di Marzo, Vincenzo; Piscitelli, Fabiana (2015) The Endocannabinoid System and its Modulation by Phytocannabinoids. En: Neurotherapeutics. Vol. 12; No. 4; pp. 692-698; 1933-7213, 1878-7479; Consultado en: 2021/02/11/23:03:15. Disponible en: http://link.springer.com/10.1007/s13311-015-0374-6. Disponible en: 10.1007/s13311-015-0374-6.
Cristino, Luigia; Bisogno, Tiziana; Di Marzo, Vincenzo (2020) Cannabinoids and the expanded endocannabinoid system in neurological disorders. En: Nature Reviews Neurology. Vol. 16; No. 1; pp. 9-29; 1759-4758, 1759-4766; Consultado en: 2021/02/11/23:13:57. Disponible en: http://www.nature.com/articles/s41582-019-0284-z. Disponible en: 10.1038/s41582-019-0284-z.
Hu, Sherry Shu-Jung; Mackie, Ken; Pertwee, Roger G. (2015) Distribution of the Endocannabinoid System in the Central Nervous System. En: Endocannabinoids. Vol. 231; pp. 59-93; Cham: Springer International Publishing; 978-3-319-20824-4 978-3-319-20825-1; Consultado en: 2021/02/11/23:15:17. Disponible en: http://link.springer.com/10.1007/978-3-319-20825-1_3.
Kaur, Ishnoor; Behl, Tapan; Bungau, Simona; Zengin, Gokhan; Kumar, Arun; El-Esawi, Mohamed A.; Khullar, Gaurav; Venkatachalam, Thangavel; Arora, Sandeep (2020) The endocannabinoid signaling pathway as an emerging target in pharmacotherapy, earmarking mitigation of destructive events in rheumatoid arthritis. En: Life Sciences. Vol. 257; pp. 118109 00243205; Consultado en: 2021/02/11/23:19:41. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0024320520308602. Disponible en: 10.1016/j.lfs.2020.118109.
Shenglong Zou; Ujendra Kumar (2018) Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. En: International Journal of Molecular Sciences. Vol. 19; No. 3; pp. 833 1422-0067; Consultado en: 2021/02/11/23:38:34. Disponible en: http://www.mdpi.com/1422-0067/19/3/833. Disponible en: 10.3390/ijms19030833.
Maccarrone, Mauro; Bab, Itai; Bíró, Tamás; Cabral, Guy A.; Dey, Sudhansu K.; Di Marzo, Vincenzo; Konje, Justin C.; Kunos, George; Mechoulam, Raphael; Pacher, Pal; Sharkey, Keith A.; Zimmer, Andreas (2015) Endocannabinoid signaling at the periphery: 50 years after THC. En: Trends in Pharmacological Sciences. Vol. 36; No. 5; pp. 277-296; 01656147; Consultado en: 2021/02/11/23:47:39. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0165614715000346. Disponible en: 10.1016/j.tips.2015.02.008.
Prospéro-García, Oscar; Ruiz Contreras, Alejandra E.; Ortega Gómez, Alette; Herrera-Solís, Andrea; Méndez-Díaz, Mónica (2019) Endocannabinoids as Therapeutic Targets. En: Archives of Medical Research. Vol. 50; No. 8; pp. 518-526; 01884409; Consultado en: 2021/02/11/23:48:06. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0188440919304746. Disponible en: 10.1016/j.arcmed.2019.09.005.
ElSohly, Mahmoud A.; Slade, Desmond (2005) Chemical constituents of marijuana: The complex mixture of natural cannabinoids. En: Life Sciences. Vol. 78; No. 5; pp. 539-548; 00243205; Consultado en: 2021/02/17/01:08:42. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S002432050500891X. Disponible en: 10.1016/j.lfs.2005.09.011.
Booth, Judith K.; Bohlmann, Jörg (2019) Terpenes in Cannabis sativa – From plant genome to humans. En: Plant Science. Vol. 284; pp. 67-72; 01689452; Consultado en: 2021/02/17/02:09:42. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0168945219301190. Disponible en: 10.1016/j.plantsci.2019.03.022.
Gallily, Ruth; Yekhtin, Zhannah; Hanuš, Lumír Ondřej (2015) Overcoming the Bell-Shaped Dose-Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol. En: Pharmacology & Pharmacy. Vol. 06; No. 02; pp. 75-85; 2157-9423, 2157-9431; Consultado en: 2021/03/21/23:20:09. Disponible en: http://www.scirp.org/journal/doi.aspx?DOI=10.4236/pp.2015.62010. Disponible en: 10.4236/pp.2015.62010.
Sousa, Cátia; Leitão, Alcino Jorge; Neves, Bruno Miguel; Judas, Fernando; Cavaleiro, Carlos; Mendes, Alexandrina Ferreira (2020) Standardised comparison of limonene-derived monoterpenes identifies structural determinants of anti-inflammatory activity. En: Scientific Reports. Vol. 10; No. 1; pp. 7199 2045-2322; Consultado en: 2021/04/02/21:23:19. Disponible en: http://www.nature.com/articles/s41598-020-64032-1. Disponible en: 10.1038/s41598-020-64032-1.
Fukuda, Shin; Kohsaka, Hitoshi; Takayasu, Aiko; Yokoyama, Waka; Miyabe, Chie; Miyabe, Yoshishige; Harigai, Masayoshi; Miyasaka, Nobuyuki; Nanki, Toshihiro (2014) Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis. En: BMC Musculoskeletal Disorders. Vol. 15; No. 1; pp. 275 1471-2474; Consultado en: 2021/04/02/22:03:25. Disponible en: http://bmcmusculoskeletdisord.biomedcentral.com/articles/10.1186/1471-2474-15-275. Disponible en: 10.1186/1471-2474-15-275.
Almogi-Hazan, Osnat; Or, Reuven (2020) Cannabis, the Endocannabinoid System and Immunity—the Journey from the Bedside to the Bench and Back. En: International Journal of Molecular Sciences. Vol. 21; No. 12; pp. 4448 1422-0067; Consultado en: 2021/04/02/22:30:18. Disponible en: https://www.mdpi.com/1422-0067/21/12/4448. Disponible en: 10.3390/ijms21124448.
Ambrose, Tim; Simmons, Alison (2019) Cannabis, Cannabinoids, and the Endocannabinoid System—Is there Therapeutic Potential for Inflammatory Bowel Disease?. En: Journal of Crohn's and Colitis. Vol. 13; No. 4; pp. 525-535; 1873-9946, 1876-4479; Consultado en: 2021/04/02/22:34:02. Disponible en: https://academic.oup.com/ecco-jcc/article/13/4/525/5173479. Disponible en: 10.1093/ecco-jcc/jjy185.
Alves, Vera L.; Gonçalves, João L.; Aguiar, Joselin; Teixeira, Helena M.; Câmara, José S. (2020) The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review. En: Critical Reviews in Toxicology. Vol. 50; No. 5; pp. 359-382; 1040-8444, 1547-6898; Consultado en: 2021/04/13/05:28:38. Disponible en: https://www.tandfonline.com/doi/full/10.1080/10408444.2020.1762539. Disponible en: 10.1080/10408444.2020.1762539.
Pacher, Pál; Kunos, George (2013) Modulating the endocannabinoid system in human health and disease. En: FEBS Journal. Vol. 280; No. 9; pp. 1918-1943; 1742464X; Consultado en: 2021/04/14/22:25:47. Disponible en: http://doi.wiley.com/10.1111/febs.12260. Disponible en: 10.1111/febs.12260.
Straus, Daniel S.; Glass, Christopher K. (2007) Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. En: Trends in Immunology. Vol. 28; No. 12; pp. 551-558; 14714906; Consultado en: 2021/05/26/05:50:25. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S147149060700244X. Disponible en: 10.1016/j.it.2007.09.003.
Blasco-Benito, Sandra; Seijo-Vila, Marta; Caro-Villalobos, Miriam; Tundidor, Isabel; Andradas, Clara; García-Taboada, Elena; Wade, Jeff; Smith, Stewart; Guzmán, Manuel; Pérez-Gómez, Eduardo; Gordon, Mara; Sánchez, Cristina (2018) Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer. En: Biochemical Pharmacology. Vol. 157; pp. 285-293; 00062952; Consultado en: 2021/05/26/20:27:59. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0006295218302387. Disponible en: 10.1016/j.bcp.2018.06.025.
Kinghorn, A. Douglas; Falk, Heinz; Gibbons, Simon; Kobayashi, Jun'ichi (2017) Phytocannabinoids: Unraveling the Complex Chemistry and Pharmacology of Cannabis sativa. En: Progress in the Chemistry of Organic Natural Products. Vol. 103; Cham: Springer International Publishing; 978-3-319-45539-6 978-3-319-45541-9; Consultado en: 2021/09/28/16:59:11. Disponible en: http://link.springer.com/10.1007/978-3-319-45541-9.
Clayton, Paul; Hill, Mariko; Bogoda, Nathasha; Subah, Silma; Venkatesh, Ruchitha (2021) Palmitoylethanolamide: A Natural Compound for Health Management. En: International Journal of Molecular Sciences. Vol. 22; No. 10; pp. 5305 1422-0067; Consultado en: 2022/03/08/15:57:16. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157570/. Disponible en: 10.3390/ijms22105305.
Beggiato, Sarah; Tomasini, Maria Cristina; Ferraro, Luca (2019) Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer’s Disease. En: Frontiers in Pharmacology. Vol. 10; pp. 821 1663-9812; Consultado en: 2022/03/17/16:36:58. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667638/. Disponible en: 10.3389/fphar.2019.00821.
Colizzi, Marco; Bortoletto, Riccardo; Costa, Rosalia; Zoccante, Leonardo (2021) Palmitoylethanolamide and Its Biobehavioral Correlates in Autism Spectrum Disorder: A Systematic Review of Human and Animal Evidence. En: Nutrients. Vol. 13; No. 4; pp. 1346 2072-6643; Consultado en: 2022/03/17/16:37:13. Disponible en: https://www.mdpi.com/2072-6643/13/4/1346. Disponible en: 10.3390/nu13041346.
Depression. Consultado en: 2022/04/04/. Disponible en: https://www.who.int/health-topics/depression.
Babagi, Hisham Fawaz; Aljifri, Noor Mohammed M; Dali, Raghdah Suliman O; Jan, Salah M; Alqahtani, Lamya Mesfer; Abusrrah, Wael Mohammed; Alfaya, Abdullah; Alqurus, Zahra Ali M; Alswilem, Abdullah Mansour (2020) An overview on unipolar major depression in adults diagnosis and management approach. pp. 7
Ménard, C.; Hodes, G.E.; Russo, S.J. (2016) Pathogenesis of depression: Insights from human and rodent studies. En: Neuroscience. Vol. 321; pp. 138-162; 03064522; Consultado en: 2022/04/14/16:45:15. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0306452215004959. Disponible en: 10.1016/j.neuroscience.2015.05.053.
Pagano, Cristina; Navarra, Giovanna; Coppola, Laura; Avilia, Giorgio; Bifulco, Maurizio; Laezza, Chiara (2022) Cannabinoids: Therapeutic Use in Clinical Practice. En: International Journal of Molecular Sciences. Vol. 23; No. 6; pp. 3344 1422-0067; Consultado en: 2022/04/15/15:40:25. Disponible en: https://www.mdpi.com/1422-0067/23/6/3344. Disponible en: 10.3390/ijms23063344.
Fernández-Ruiz, Javier; Galve-Roperh, Ismael; Sagredo, Onintza; Guzmán, Manuel (2020) Possible therapeutic applications of cannabis in the neuropsychopharmacology field. En: European Neuropsychopharmacology. Vol. 36; pp. 217-234; 0924977X; Consultado en: 2022/04/15/15:43:03. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0924977X20300365. Disponible en: 10.1016/j.euroneuro.2020.01.013.
Poleszak, Ewa; Wośko, Sylwia; Sławińska, Karolina; Szopa, Aleksandra; Wróbel, Andrzej; Serefko, Anna (2018) Cannabinoids in depressive disorders. En: Life Sciences. Vol. 213; pp. 18-24; 00243205; Consultado en: 2022/04/15/15:43:48. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0024320518306040. Disponible en: 10.1016/j.lfs.2018.09.058.
Chadwick, Verity L.; Rohleder, Cathrin; Koethe, Dagmar; Leweke, F. Markus (2020) Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans. En: Current Opinion in Psychiatry. Vol. 33; No. 1; pp. 20-42; 0951-7367; Consultado en: 2022/04/15/15:49:17. Disponible en: https://journals.lww.com/10.1097/YCO.0000000000000562. Disponible en: 10.1097/YCO.0000000000000562.
Corroon, Jamie; Felice, Jake F (2019) The Endocannabinoid System and its Modulation by Cannabidiol (CBD). En: Alternative Therapies in Health & Medicine. Vol. 25; 1078-6791
Bilge, Serap; Ekici, Barış (2021) CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature. En: Journal of Cannabis Research. Vol. 3; No. 1; pp. 53 2522-5782; Consultado en: 2022/04/16/23:07:13. Disponible en: https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-021-00108-7. Disponible en: 10.1186/s42238-021-00108-7.
Anand, Uma; Pacchetti, Barbara; Anand, Praveen; Sodergren, Mikael Hans (2021) Cannabis-based medicines and pain: a review of potential synergistic and entourage effects. En: Pain Management. Vol. 11; No. 4; pp. 395-403; 1758-1869, 1758-1877; Consultado en: 2022/04/16/23:13:50. Disponible en: https://www.futuremedicine.com/doi/10.2217/pmt-2020-0110. Disponible en: 10.2217/pmt-2020-0110.
Di Giacomo, Silvia; Mariano, Alessia; Gullì, Marco; Fraschetti, Caterina; Vitalone, Annabella; Filippi, Antonello; Mannina, Luisa; Scotto d’Abusco, Anna; Di Sotto, Antonella (2021) Role of Caryophyllane Sesquiterpenes in the Entourage Effect of Felina 32 Hemp Inflorescence Phytocomplex in Triple Negative MDA-MB-468 Breast Cancer Cells. En: Molecules. Vol. 26; No. 21; pp. 6688 1420-3049; Consultado en: 2022/04/17/01:13:20. Disponible en: https://www.mdpi.com/1420-3049/26/21/6688. Disponible en: 10.3390/molecules26216688.
LaVigne, Justin E.; Hecksel, Ryan; Keresztes, Attila; Streicher, John M. (2021) Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity. En: Scientific Reports. Vol. 11; No. 1; pp. 8232 2045-2322; Consultado en: 2022/04/17/04:19:57. Disponible en: http://www.nature.com/articles/s41598-021-87740-8. Disponible en: 10.1038/s41598-021-87740-8.
Bautista, Johanna L.; Yu, Shu; Tian, Li (2021) Flavonoids in Cannabis sativa: Biosynthesis, Bioactivities, and Biotechnology. En: ACS Omega. Vol. 6; No. 8; pp. 5119-5123; 2470-1343, 2470-1343; Consultado en: 2022/04/17/04:23:56. Disponible en: https://pubs.acs.org/doi/10.1021/acsomega.1c00318. Disponible en: 10.1021/acsomega.1c00318.
Clayton, Paul; Subah, Silma; Venkatesh, Ruchitha; Hill, Mariko; Bogoda, Nathasha (2021) Palmitoylethanolamide: A Potential Alternative to Cannabidiol. En: Journal of Dietary Supplements. pp. 1-26; 1939-0211, 1939-022X; Consultado en: 2022/04/17/05:01:23. Disponible en: https://www.tandfonline.com/doi/full/10.1080/19390211.2021.2005733. Disponible en: 10.1080/19390211.2021.2005733.
Rankin, Linda; Fowler, Christopher J. (2020) The Basal Pharmacology of Palmitoylethanolamide. En: International Journal of Molecular Sciences. Vol. 21; No. 21; pp. 7942 1422-0067; Consultado en: 2022/04/17/20:46:04. Disponible en: https://www.mdpi.com/1422-0067/21/21/7942. Disponible en: 10.3390/ijms21217942.
Nasri, Hamid; Baradaran, Azar; Shirzad, Hedayatollah; Rafieian‑Kopaei, Mahmoud (2014) New Concepts in Nutraceuticals as Alternative for Pharmaceuticals. En: International Journal of Preventive Medicine. Vol. 5; No. 12; pp. 13
Ghazizadeh-Hashemi, Maryam; Ghajar, Alireza; Shalbafan, Mohammad-Reza; Ghazizadeh-Hashemi, Fatemeh; Afarideh, Mohsen; Malekpour, Farzaneh; Ghaleiha, Ali; Ardebili, Mehrdad Eftekhar; Akhondzadeh, Shahin (2018) Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial. En: Journal of Affective Disorders. Vol. 232; pp. 127-133; 01650327; Consultado en: 2022/04/17/23:08:38. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0165032717324278. Disponible en: 10.1016/j.jad.2018.02.057.
Gaoni, Y.; Mechoulam, R. (1964) Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish. En: Journal of the American Chemical Society. Vol. 86; No. 8; pp. 1646-1647; 0002-7863, 1520-5126; Consultado en: 2022/04/19/15:06:08. Disponible en: https://pubs.acs.org/doi/abs/10.1021/ja01062a046. Disponible en: 10.1021/ja01062a046.
Devane, William A.; Hanuš, Lumir; Breuer, Aviva; Pertwee, Roger G.; Stevenson, Lesley A.; Griffin, Graeme; Gibson, Dan; Mandelbaum, Asher; Etinger, Alexander; Mechoulam, Raphael (1992) Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor. En: Science. Vol. 258; No. 5090; pp. 1946-1949; 0036-8075, 1095-9203; Consultado en: 2022/04/19/15:33:12. Disponible en: https://www.science.org/doi/10.1126/science.1470919. Disponible en: 10.1126/science.1470919.
Mechoulam, Raphael; Ben-Shabat, Shimon; Hanus, Lumir; Ligumsky, Moshe; Kaminski, Norbert E.; Schatz, Anthony R.; Gopher, Asher; Almog, Shlomo; Martin, Billy R.; Compton, David R.; Pertwee, Roger G.; Griffin, Graeme; Bayewitch, Michael; Barg, Jacob; Vogel, Zvi (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. En: Biochemical Pharmacology. Vol. 50; No. 1; pp. 83-90; 00062952; Consultado en: 2022/04/19/15:37:31. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/000629529500109D. Disponible en: 10.1016/0006-2952(95)00109-D.
Matsuda, Lisa A; Lolait, Stephen J; Brownstein, Michael J; Young, Alice C; Bonner, Tom I (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. En: Nature. Vol. 346; No. 6284; pp. 561-564; 1476-4687; Disponible en: 10.1038/346561a0.
Munro, Sean; Thomas, Kerrie L; Abu-Shaar, Muna (1993) Molecular characterization of a peripheral receptor for cannabinoids. En: Nature. Vol. 365; No. 6441; pp. 61-65; 1476-4687; Disponible en: 10.1038/365061a0.
Centonze, Diego; Finazzi-Agro, Alessandro; Bernardi, Giorgio; Maccarrone, Mauro (2007) The endocannabinoid system in targeting inflammatory neurodegenerative diseases. En: Trends in pharmacological sciences. Vol. 28; No. 4; pp. 180-187; 0165-6147; Disponible en: 10.1016/j.tips.2007.02.004.
Skaper, Stephen D; Di Marzo, Vincenzo (2012) Endocannabinoids in nervous system health and disease: the big picture in a nutshell. En: Philosophical Transactions of the Royal Society B: Biological Sciences. Vol. 367; No. 1607; pp. 3193-3200; 0962-8436; Disponible en: 10.1098/rstb.2012.0313.
Klein, Thomas W (2005) Cannabinoid-based drugs as anti-inflammatory therapeutics. En: Nature Reviews Immunology. Vol. 5; No. 5; pp. 400-411; 1474-1741; Disponible en: 10.1038/nri1602.
Pacher, Pál; Mukhopadhyay, Partha; Mohanraj, Rajesh; Godlewski, Grzegorz; Bátkai, Sándor; Kunos, George (2008) Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations. En: Hypertension. Vol. 52; No. 4; pp. 601-607; 0194-911X; Disponible en: 10.1161/HYPERTENSIONAHA.105.063651.
Guindon, Josée; Hohmann, Andrea G (2009) The endocannabinoid system and pain. En: CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders). Vol. 8; No. 6; pp. 403-421; 1871-5273; Disponible en: 10.2174/187152709789824660.
Velasco, Guillermo; Sánchez, Cristina; Guzmán, Manuel (2012) Towards the use of cannabinoids as antitumour agents. En: Nature Reviews Cancer. Vol. 12; No. 6; pp. 436-444; 1474-1768; Disponible en: 10.1038/nrc3247.
Huang, Wen-Juan; Chen, Wei-Wei; Zhang, Xia (2016) Endocannabinoid system: Role in depression, reward and pain control (Review). En: Molecular Medicine Reports. Vol. 14; No. 4; pp. 2899-2903; 1791-2997, 1791-3004; Consultado en: 2022/04/23/03:07:30. Disponible en: https://www.spandidos-publications.com/10.3892/mmr.2016.5585. Disponible en: 10.3892/mmr.2016.5585.
Lowe, Henry; Toyang, Ngeh; Steele, Blair; Bryant, Joseph; Ngwa, Wilfred (2021) The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases. En: International Journal of Molecular Sciences. Vol. 22; No. 17; pp. 9472 1422-0067; Consultado en: 2022/04/23/03:11:57. Disponible en: https://www.mdpi.com/1422-0067/22/17/9472. Disponible en: 10.3390/ijms22179472.
Navarrete, Francisco; García-Gutiérrez, María Salud; Jurado-Barba, Rosa; Rubio, Gabriel; Gasparyan, Ani; Austrich-Olivares, Amaya; Manzanares, Jorge (2020) Endocannabinoid System Components as Potential Biomarkers in Psychiatry. En: Frontiers in Psychiatry. Vol. 11; pp. 315 1664-0640; Consultado en: 2022/04/23/03:13:43. Disponible en: https://www.frontiersin.org/article/10.3389/fpsyt.2020.00315/full. Disponible en: 10.3389/fpsyt.2020.00315.
Zádor, Ferenc; Joca, Sâmia; Nagy-Grócz, Gábor; Dvorácskó, Szabolcs; Szűcs, Edina; Tömböly, Csaba; Benyhe, Sándor; Vécsei, László (2021) Pro-Inflammatory Cytokines: Potential Links between the Endocannabinoid System and the Kynurenine Pathway in Depression. En: International Journal of Molecular Sciences. Vol. 22; No. 11; pp. 5903 1422-0067; Consultado en: 2022/04/23/03:16:31. Disponible en: https://www.mdpi.com/1422-0067/22/11/5903. Disponible en: 10.3390/ijms22115903.
Graczyk, Michał; Łukowicz, Małgorzata; Dzierzanowski, Tomasz (2021) Prospects for the Use of Cannabinoids in Psychiatric Disorders. En: Frontiers in Psychiatry. Vol. 12; pp. 620073 1664-0640; Consultado en: 2022/04/23/03:20:25. Disponible en: https://www.frontiersin.org/articles/10.3389/fpsyt.2021.620073/full. Disponible en: 10.3389/fpsyt.2021.620073.
Kasatkina, Ludmila A.; Rittchen, Sonja; Sturm, Eva M. (2021) Neuroprotective and Immunomodulatory Action of the Endocannabinoid System under Neuroinflammation. En: International Journal of Molecular Sciences. Vol. 22; No. 11; pp. 5431 1422-0067; Consultado en: 2022/04/23/03:20:36. Disponible en: https://www.mdpi.com/1422-0067/22/11/5431. Disponible en: 10.3390/ijms22115431.
Smaga, Irena; Bystrowska, Beata; Gawlinski, Dawid; Przegalinski, Edmund; Filip, Malgorzata (2014) The Endocannabinoid/Endovanilloid System and Depression. En: Current Neuropharmacology. Vol. 12; No. 5; pp. 462-474; 1570159X; Consultado en: 2022/04/23/03:21:01. Disponible en: http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1570-159X&volume=12&issue=5&spage=462. Disponible en: 10.2174/1570159X12666140923205412.
Garani, Ranjini; Watts, Jeremy J.; Mizrahi, Romina (2021) Endocannabinoid system in psychotic and mood disorders, a review of human studies. En: Progress in Neuro-Psychopharmacology and Biological Psychiatry. Vol. 106; pp. 110096 02785846; Consultado en: 2022/04/23/03:21:53. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0278584620304127. Disponible en: 10.1016/j.pnpbp.2020.110096.
Yarar, Erhan (2020) Role and Function of Endocannabinoid System in Major Depressive Disease. En: Medical Cannabis and Cannabinoids. Vol. 4; No. 1; pp. 1-12; 2504-3889; Consultado en: 2022/04/23/03:23:06. Disponible en: https://www.karger.com/Article/FullText/511979. Disponible en: 10.1159/000511979.
Rana, Tarapati; Behl, Tapan; Sehgal, Aayush; Mehta, Vineet; Singh, Sukhbir; Kumar, Ravinder; Bungau, Simona (2021) Integrating Endocannabinoid Signalling In Depression. En: Journal of Molecular Neuroscience. Vol. 71; No. 10; pp. 2022-2034; 0895-8696, 1559-1166; Consultado en: 2022/04/23/03:24:41. Disponible en: https://link.springer.com/10.1007/s12031-020-01774-7. Disponible en: 10.1007/s12031-020-01774-7.
Pariante, Carmine M; Why are depressed patients inflamed? A reflection on 20 years of research on depression, glucocorticoid resistance and inflammation. pp. 6 Disponible en: 10.1016/j.euroneuro.2017.04.001.
Anisman, H; Merali, Z (2002) Cytokines, stress, and depressive illness. pp. 12 Disponible en: 10.1016/s0889-1591(02)00009-0.
Adamczyk, P; Golda, A; McCreary, AC; Filip, M; Przegaliriski, E (2008) Activation of endocannabinoid transmission induces antidepressant-like effects in rats. En: Acta physiologica Polonica. Vol. 59; No. 2; pp. 217 0044-6033
Umathe, Sudhir N; Manna, Shyamshree SS; Jain, Nishant S (2011) Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice. En: Behavioural brain research. Vol. 223; No. 1; pp. 125-134; 0166-4328; Disponible en: 10.1016/j.bbr.2011.04.031.
Shearman, LP; Rosko, KM; Fleischer, R; Wang, J; Xu, S; Tong, XS; Rocha, Beatriz A (2003) Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice. En: Behavioural pharmacology. Vol. 14; No. 8; pp. 573-582; 0955-8810; Disponible en: 10.1097/00008877-200312000-00001.
Tzavara, Eleni T; Davis, Richard J; Perry, Kenneth W; Li, Xia; Salhoff, Craig; Bymaster, Frank P; Witkin, Jeffrey M; Nomikos, George G (2003) The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions. En: British journal of pharmacology. Vol. 138; No. 4; pp. 544-553; 0007-1188; Disponible en: 10.1038/sj.bjp.0705100.
Petrosino, Stefania; Di Marzo, Vincenzo (2017) The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations. En: British Journal of Pharmacology. Vol. 174; No. 11; pp. 1349-1365; 00071188; Consultado en: 2022/04/26/15:48:54. Disponible en: https://onlinelibrary.wiley.com/doi/10.1111/bph.13580. Disponible en: 10.1111/bph.13580.
Okamoto, Yasuo; Morishita, Jun; Tsuboi, Kazuhito; Tonai, Takeharu; Ueda, Natsuo (2004) Molecular characterization of a phospholipase D generating anandamide and its congeners. En: Journal of Biological Chemistry. Vol. 279; No. 7; pp. 5298-5305; 0021-9258; Disponible en: 10.1074/jbc.M306642200.
Ueda, Natsuo; Yamanaka, Kenji; Yamamoto, Shozo (2001) Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance. En: Journal of Biological Chemistry. Vol. 276; No. 38; pp. 35552-35557; 0021-9258; Disponible en: 10.1074/jbc.M106261200.
Bougarne, Nadia; Weyers, Basiel; Desmet, Sofie J; Deckers, Julie; Ray, David W; Staels, Bart; De Bosscher, Karolien (2018) Molecular actions of PPAR α in lipid metabolism and inflammation. En: Endocrine reviews. Vol. 39; No. 5; pp. 760-802; 0163-769X; Disponible en: 10.1210/er.2018-00064.
Lo Verme, Jesse; Fu, Jin; Astarita, Giuseppe; La Rana, Giovanna; Russo, Roberto; Calignano, Antonio; Piomelli, Daniele (2005) The Nuclear Receptor Peroxisome Proliferator-Activated Receptor-α Mediates the Anti-Inflammatory Actions of Palmitoylethanolamide. En: Molecular Pharmacology. Vol. 67; No. 1; pp. 15-19; 0026-895X, 1521-0111; Consultado en: 2022/04/28/17:27:18. Disponible en: http://molpharm.aspetjournals.org/lookup/doi/10.1124/mol.104.006353. Disponible en: 10.1124/mol.104.006353.
LoVerme, Jesse; La Rana, Giovanna; Russo, Roberto; Calignano, Antonio; Piomelli, Daniele (2005) The search for the palmitoylethanolamide receptor. En: Life Sciences. Vol. 77; No. 14; pp. 1685-1698; 00243205; Consultado en: 2022/04/28/17:28:28. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0024320505004911. Disponible en: 10.1016/j.lfs.2005.05.012.
Iannotti, Fabio Arturo; Vitale, Rosa Maria (2021) The Endocannabinoid System and PPARs: Focus on Their Signalling Crosstalk, Action and Transcriptional Regulation. En: Cells. Vol. 10; No. 3; pp. 586 2073-4409; Consultado en: 2022/04/28/19:52:30. Disponible en: https://www.mdpi.com/2073-4409/10/3/586. Disponible en: 10.3390/cells10030586.
Esposito, Emanuela; Cuzzocrea, Salvatore (2013) Palmitoylethanolamide in homeostatic and traumatic central nervous system injuries. En: CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders). Vol. 12; No. 1; pp. 55-61; 1871-5273; Disponible en: 10.2174/1871527311312010010.
Cordaro, Marika; Impellizzeri, Daniela; Paterniti, Irene; Bruschetta, Giuseppe; Siracusa, Rosalba; De Stefano, Daniela; Cuzzocrea, Salvatore; Esposito, Emanuela (2016) Neuroprotective effects of Co-ultraPEALut on secondary inflammatory process and autophagy involved in traumatic brain injury. En: Journal of neurotrauma. Vol. 33; No. 1; pp. 132-146; 0897-7151; Disponible en: 10.1089/neu.2014.3460.
Cruzblanca, Humberto; Lupercio, Patricia; Collas, Jorge; Castro, Elena; Centro Universitario de Investigaciones Biomédicas, Universidad de Colima, Colima, Col., México. (2016) Neurobiología de la depresión mayor y de su tratamiento farmacológico. En: Salud mental. Vol. 39; No. 1; pp. 47-58; 0185-3325; Consultado en: 2022/05/04/23:53:18. Disponible en: http://revistasaludmental.mx/index.php/salud_mental/article/view/SM.0185-3325.2015.067. Disponible en: 10.17711/SM.0185-3325.2015.067.
Beurel, Eléonore; Toups, Marisa; Nemeroff, Charles B. (2020) The Bidirectional Relationship of Depression and Inflammation: Double Trouble. En: Neuron. Vol. 107; No. 2; pp. 234-256; 08966273; Consultado en: 2022/05/05/00:58:32. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0896627320304311. Disponible en: 10.1016/j.neuron.2020.06.002.
Andre, Christelle M; Hausman, Jean-Francois; Guerriero, Gea (2016) Cannabis sativa: the plant of the thousand and one molecules. En: Frontiers in plant science. Vol. 7; pp. 19 1664-462X; Disponible en: 10.3389/fpls.2016.00019.
Wasserman, Danuta (2011) Depression. : OUP Oxford; 0-19-163151-5
Li, Gang; Zhang, Ling; DiBernardo, Allitia; Wang, Grace; Sheehan, John J.; Lee, Kwan; Reutfors, Johan; Zhang, Qiaoyi; Wilson, Fernando A. (2020) A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients. En: PLOS ONE. Vol. 15; No. 9; pp. e0238843 1932-6203; Consultado en: 2022/06/16/22:20:57. Disponible en: https://dx.plos.org/10.1371/journal.pone.0238843. Disponible en: 10.1371/journal.pone.0238843.
Kennedy, Sidney H; Lam, Raymond W; Nutt, David J; Thase, Michael (2004) Treating depression effectively. : SciELO Espana; 1-84184-328-8
Burstein, Sumner H.; Zurier, Robert B. (2009) Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation. En: The AAPS Journal. Vol. 11; No. 1; pp. 109 1550-7416; Consultado en: 2022/07/23/04:14:35. Disponible en: http://link.springer.com/10.1208/s12248-009-9084-5. Disponible en: 10.1208/s12248-009-9084-5.
Ministerio de Salud y Protección Social de Colombia (2017) Boletín de salud mental: Depresión. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/ENT/boletin-depresion-marzo-2017.pdf.
Departamento Administrativo Nacional De Estadística (2021) Salud mental en Colombia: Un análisis de los efectos de la pandemia. Disponible en: https://ascofapsi.org.co/pdf/Noticias/Estad%C3%ADstica%20de%20Salud%20mental%20en%20Colombia-%20pandemia%202021%20.pdf.
Rice, Frances (2010) Genetics of childhood and adolescent depression: insights into etiological heterogeneity and challenges for future genomic research. En: Genome Medicine. Vol. 2; No. 9; pp. 68 1756-994X; Consultado en: 2022/07/23/07:09:48. Disponible en: http://genomemedicine.biomedcentral.com/articles/10.1186/gm189. Disponible en: 10.1186/gm189.
Holmans, Peter; Zubenko, George S.; Crowe, Raymond R.; DePaulo, J. Raymond; Scheftner, William A.; Weissman, Myrna M.; Zubenko, Wendy N.; Boutelle, Sandra; Murphy-Eberenz, Kathleen; MacKinnon, Dean; McInnis, Melvin G.; Marta, Diana H.; Adams, Philip; Knowles, James A.; Gladis, Madeleine; Thomas, Jo; Chellis, Jennifer; Miller, Erin; Levinson, Douglas F. (2004) Genomewide Significant Linkage to Recurrent, Early-Onset Major Depressive Disorder on Chromosome 15q. En: The American Journal of Human Genetics. Vol. 74; No. 6; pp. 1154-1167; 00029297; Consultado en: 2022/07/23/07:11:48. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0002929707628420. Disponible en: 10.1086/421333.
Abkevich, Victor; Camp, Nicola J.; Hensel, Charles H.; Neff, Chris D.; Russell, Deanna L.; Hughes, Dana C.; Plenk, Agnes M.; Lowry, Michael R.; Richards, R. Lynn; Carter, Catherine; Frech, Georges C.; Stone, Steven; Rowe, Kerry; Chau, Chi Ai; Cortado, Kathleen; Hunt, Angelene; Luce, Karanina; O’Neil, Gayanne; Poarch, Jeff; Potter, Jennifer; Poulsen, Gregg H.; Saxton, Heidi; Bernat-Sestak, Michelle; Thompson, Victor; Gutin, Alexander; Skolnick, Mark H.; Shattuck, Donna; Cannon-Albright, Lisa (2003) Predisposition Locus for Major Depression at Chromosome 12q22-12q23.2. En: The American Journal of Human Genetics. Vol. 73; No. 6; pp. 1271-1281; 00029297; Consultado en: 2022/07/23/07:12:38. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0002929707639809. Disponible en: 10.1086/379978.
Yamada, Kazuo; Hattori, Eiji; Iwayama, Yoshimi; Ohnishi, Tetsuo; Ohba, Hisako; Toyota, Tomoko; Takao, Hitomi; Minabe, Yoshio; Nakatani, Noriaki; Higuchi, Teruhiko; Detera-Wadleigh, Sevilla D.; Yoshikawa, Takeo (2006) Distinguishable Haplotype Blocks in the HTR3A and HTR3B Region in the Japanese Reveal Evidence of Association of HTR3B with Female Major Depression. En: Biological Psychiatry. Vol. 60; No. 2; pp. 192-201; 00063223; Consultado en: 2022/07/23/07:14:22. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0006322305013983. Disponible en: 10.1016/j.biopsych.2005.11.008.
Binder, Elisabeth B; Salyakina, Daria; Lichtner, Peter; Wochnik, Gabriele M; Ising, Marcus; Pütz, Benno; Papiol, Sergi; Seaman, Shaun; Lucae, Susanne; Kohli, Martin A; Nickel, Thomas; Künzel, Heike E; Fuchs, Brigitte; Majer, Matthias; Pfennig, Andrea; Kern, Nikola; Brunner, Jürgen; Modell, Sieglinde; Baghai, Thomas; Deiml, Tobias; Zill, Peter; Bondy, Brigitta; Rupprecht, Rainer; Messer, Thomas; Köhnlein, Oliver; Dabitz, Heike; Brückl, Tanja; Müller, Nina; Pfister, Hildegard; Lieb, Roselind; Mueller, Jakob C; Lõhmussaar, Elin; Strom, Tim M; Bettecken, Thomas; Meitinger, Thomas; Uhr, Manfred; Rein, Theo; Holsboer, Florian; Muller-Myhsok, Bertram (2004) Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. En: Nature Genetics. Vol. 36; No. 12; pp. 1319-1325; 1061-4036, 1546-1718; Consultado en: 2022/07/23/07:15:47. Disponible en: http://www.nature.com/articles/ng1479. Disponible en: 10.1038/ng1479.
Uhr, Manfred; Tontsch, Alina; Namendorf, Christian; Ripke, Stephan; Lucae, Susanne; Ising, Marcus; Dose, Tatjana; Ebinger, Martin; Rosenhagen, Marcus; Kohli, Martin; Kloiber, Stefan; Salyakina, Daria; Bettecken, Thomas; Specht, Michael; Pütz, Benno; Binder, Elisabeth B.; Müller-Myhsok, Bertram; Holsboer, Florian (2008) Polymorphisms in the Drug Transporter Gene ABCB1 Predict Antidepressant Treatment Response in Depression. En: Neuron. Vol. 57; No. 2; pp. 203-209; 08966273; Consultado en: 2022/07/23/07:17:23. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0896627307009750. Disponible en: 10.1016/j.neuron.2007.11.017.
Bishop, Jeffrey R; Moline, Jessica; Ellingrod, Vicki L; Schultz, Susan K; Clayton, Anita H (2006) Serotonin 2A −1438 G/A and G-Protein Beta3 Subunit C825T Polymorphisms in Patients with Depression and SSRI-Associated Sexual Side-Effects. En: Neuropsychopharmacology. Vol. 31; No. 10; pp. 2281-2288; 0893-133X, 1740-634X; Consultado en: 2022/07/23/07:17:49. Disponible en: http://www.nature.com/articles/1301090. Disponible en: 10.1038/sj.npp.1301090.
Bruce, Martha L (2002) Psychosocial risk factors for depressive disorders in late life. En: Biological Psychiatry. Vol. 52; No. 3; pp. 175-184; 00063223; Consultado en: 2022/07/23/07:19:43. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0006322302014105. Disponible en: 10.1016/S0006-3223(02)01410-5.
Frodl, Thomas; Reinhold, Elena; Koutsouleris, Nikolaos; Donohoe, Gary; Bondy, Brigitta; Reiser, Maximilian; Möller, Hans-Jürgen; Meisenzahl, Eva M (2010) Childhood Stress, Serotonin Transporter Gene and Brain Structures in Major Depression. En: Neuropsychopharmacology. Vol. 35; No. 6; pp. 1383-1390; 0893-133X, 1740-634X; Consultado en: 2022/07/23/07:23:04. Disponible en: http://www.nature.com/articles/npp20108. Disponible en: 10.1038/npp.2010.8.
Karg, Katja; Burmeister, Margit; Shedden, Kerby; Sen, Srijan (2011) The Serotonin Transporter Promoter Variant (5-HTTLPR), Stress, and Depression Meta-analysis Revisited: Evidence of Genetic Moderation. En: Archives of General Psychiatry. Vol. 68; No. 5; pp. 444 0003-990X; Consultado en: 2022/07/23/07:24:03. Disponible en: http://archpsyc.jamanetwork.com/article.aspx?doi=10.1001/archgenpsychiatry.2010.189. Disponible en: 10.1001/archgenpsychiatry.2010.189.
Edition, Fifth (2013) Diagnostic and statistical manual of mental disorders. En: Am Psychiatric Assoc. Vol. 21; No. 21; pp. 591-643
Manual MSD versión para profesionales; Trastornos depresivos. Disponible en: https://www.msdmanuals.com/es/professional/trastornos-psiquiátricos/trastornos-del-estado-de-ánimo/trastornos-depresivos.
Siegmann, Eva-Maria; Müller, Helge H. O.; Luecke, Caroline; Philipsen, Alexandra; Kornhuber, Johannes; Grömer, Teja Wolfgang (2018) Association of Depression and Anxiety Disorders With Autoimmune Thyroiditis: A Systematic Review and Meta-analysis. En: JAMA Psychiatry. Vol. 75; No. 6; pp. 577 2168-622X; Consultado en: 2022/07/23/07:58:36. Disponible en: http://archpsyc.jamanetwork.com/article.aspx?doi=10.1001/jamapsychiatry.2018.0190. Disponible en: 10.1001/jamapsychiatry.2018.0190.
Ko, Dennis T. (2002) β-Blocker Therapy and Symptoms of Depression, Fatigue, and Sexual Dysfunction. En: JAMA. Vol. 288; No. 3; pp. 351 0098-7484; Consultado en: 2022/07/23/08:00:41. Disponible en: http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.288.3.351. Disponible en: 10.1001/jama.288.3.351.
Mele, Bria; Watt, Jennifer; Wu, Pauline; Azeem, Feeha; Lew, Grace; Holroyd–Leduc, Jayna; Goodarzi, Zahra (2022) Detecting depression in persons living in long-term care: a systematic review and meta-analysis of diagnostic test accuracy studies. En: Age and Ageing. Vol. 51; No. 3; pp. afac039 0002-0729, 1468-2834; Consultado en: 2022/07/23/08:03:58. Disponible en: https://academic.oup.com/ageing/article/doi/10.1093/ageing/afac039/6540127. Disponible en: 10.1093/ageing/afac039.
Chambless, Dianne L. (1993) Task Force on Promotion and Dissemination of Psychological Procedures: A Report Adopted by the Division 12 Board-October 1993: (550782009-001). : American Psychological Association; Consultado en: 2022/07/23/08:10:03. Disponible en: http://doi.apa.org/get-pe-doi.cfm?doi=10.1037/e550782009-001.
Chambless, Dianne L.; Hollon, Steven D. (1998) Defining empirically supported therapies. En: Journal of Consulting and Clinical Psychology. Vol. 66; No. 1; pp. 7-18; 1939-2117, 0022-006X; Consultado en: 2022/07/23/08:11:16. Disponible en: http://doi.apa.org/getdoi.cfm?doi=10.1037/0022-006X.66.1.7. Disponible en: 10.1037/0022-006X.66.1.7.
Hollon, Steven D.; Ponniah, Kathryn (2010) A review of empirically supported psychological therapies for mood disorders in adults. En: Depression and Anxiety. Vol. 27; No. 10; pp. 891-932; 10914269; Consultado en: 2022/07/23/08:15:11. Disponible en: https://onlinelibrary.wiley.com/doi/10.1002/da.20741. Disponible en: 10.1002/da.20741.
Miniati, Mario; Marzetti, Francesca; Palagini, Laura; Conversano, Ciro; Buccianelli, Beatrice; Marazziti, Donatella; Gemignani, Angelo (2021) Telephone-delivered Interpersonal Psychotherapy: a systematic review. En: CNS Spectrums. pp. 1-13; 1092-8529, 2165-6509; Consultado en: 2022/07/23/08:17:14. Disponible en: https://www.cambridge.org/core/product/identifier/S1092852921000948/type/journal_article. Disponible en: 10.1017/S1092852921000948.
Bernecker, Samantha L.; Coyne, Alice E.; Constantino, Michael J.; Ravitz, Paula (2017) For whom does interpersonal psychotherapy work? A systematic review. En: Clinical Psychology Review. Vol. 56; pp. 82-93; 02727358; Consultado en: 2022/07/23/08:18:51. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0272735817300120. Disponible en: 10.1016/j.cpr.2017.07.001.
Zhang, Anao; Borhneimer, Lindsay A.; Weaver, Addie; Franklin, Cynthia; Hai, Audrey Hang; Guz, Samantha; Shen, Li (2019) Cognitive behavioral therapy for primary care depression and anxiety: a secondary meta-analytic review using robust variance estimation in meta-regression. En: Journal of Behavioral Medicine. Vol. 42; No. 6; pp. 1117-1141; 0160-7715, 1573-3521; Consultado en: 2022/07/23/08:21:10. Disponible en: http://link.springer.com/10.1007/s10865-019-00046-z. Disponible en: 10.1007/s10865-019-00046-z.
Zhang, Anao; Franklin, Cynthia; Jing, Shijie; Bornheimer, Lindsay A.; Hai, Audrey Hang; Himle, Joseph A.; Kong, Dexia; Ji, Qingying (2019) The effectiveness of four empirically supported psychotherapies for primary care depression and anxiety: A systematic review and meta-analysis. En: Journal of Affective Disorders. Vol. 245; pp. 1168-1186; 01650327; Consultado en: 2022/07/23/08:23:34. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0165032718319608. Disponible en: 10.1016/j.jad.2018.12.008.
Nezu, Arthur M; Nezu, CM; D’zurilla, TJ (2007) Solving life’s problems. En: New York, US.
Hopko, Derek R.; Lejuez, C.W.; Ruggiero, Kenneth J.; Eifert, Georg H. (2003) Contemporary behavioral activation treatments for depression: Procedures, principles, and progress. En: Clinical Psychology Review. Vol. 23; No. 5; pp. 699-717; 02727358; Consultado en: 2022/07/23/08:27:07. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0272735803000709. Disponible en: 10.1016/S0272-7358(03)00070-9.
Cipriani, Andrea; Furukawa, Toshi A; Salanti, Georgia; Chaimani, Anna; Atkinson, Lauren Z; Ogawa, Yusuke; Leucht, Stefan; Ruhe, Henricus G; Turner, Erick H; Higgins, Julian P T; Egger, Matthias; Takeshima, Nozomi; Hayasaka, Yu; Imai, Hissei; Shinohara, Kiyomi; Tajika, Aran; Ioannidis, John P A; Geddes, John R (2018) Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis. En: FOCUS. Vol. 16; No. 4; pp. 420-429; 1541-4094, 1541-4108; Consultado en: 2022/07/23/08:29:07. Disponible en: https://psychiatryonline.org/doi/10.1176/appi.focus.16407. Disponible en: 10.1176/appi.focus.16407.
Pinquart, Martin; Duberstein, Paul R.; Lyness, Jeffrey M. (2006) Treatments for Later-Life Depressive Conditions: A Meta-Analytic Comparison of Pharmacotherapy and Psychotherapy. En: American Journal of Psychiatry. Vol. 163; No. 9; pp. 1493-1501; 0002-953X, 1535-7228; Consultado en: 2022/07/23/08:31:52. Disponible en: http://psychiatryonline.org/doi/abs/10.1176/ajp.2006.163.9.1493. Disponible en: 10.1176/ajp.2006.163.9.1493.
American Psychological Association (2019) Clinical practice guideline for the treatment of depression across three age cohorts. En: Washington, DC: Author.
Hetrick, Sarah E; McKenzie, Joanne E; Bailey, Alan P; Sharma, Vartika; Moller, Carl I; Badcock, Paul B; Cox, Georgina R; Merry, Sally N; Meader, Nicholas; Cochrane Common Mental Disorders Group (2021) New generation antidepressants for depression in children and adolescents: a network meta-analysis. En: Cochrane Database of Systematic Reviews. Vol. 2021; No. 5; 14651858; Consultado en: 2022/07/23/08:37:28. Disponible en: http://doi.wiley.com/10.1002/14651858.CD013674.pub2. Disponible en: 10.1002/14651858.CD013674.pub2.
Rush, A. John; Trivedi, Madhukar H.; Stewart, Jonathan W.; Nierenberg, Andrew A.; Fava, Maurizio; Kurian, Benji T.; Warden, Diane; Morris, David W.; Luther, James F.; Husain, Mustafa M.; Cook, Ian A.; Shelton, Richard C.; Lesser, Ira M.; Kornstein, Susan G.; Wisniewski, Stephen R. (2011) Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study. En: American Journal of Psychiatry. Vol. 168; No. 7; pp. 689-701; 0002-953X, 1535-7228; Consultado en: 2022/07/23/08:39:42. Disponible en: http://psychiatryonline.org/doi/abs/10.1176/appi.ajp.2011.10111645. Disponible en: 10.1176/appi.ajp.2011.10111645.
Canuso, Carla M.; Singh, Jaskaran B.; Fedgchin, Maggie; Alphs, Larry; Lane, Rosanne; Lim, Pilar; Pinter, Christine; Hough, David; Sanacora, Gerard; Manji, Husseini; Drevets, Wayne C. (2018) Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study. En: American Journal of Psychiatry. Vol. 175; No. 7; pp. 620-630; 0002-953X, 1535-7228; Consultado en: 2022/07/23/08:42:13. Disponible en: http://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2018.17060720. Disponible en: 10.1176/appi.ajp.2018.17060720.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Introducción: La depresión es una de las patologías psiquiátricas más prevalentes en el mundo. Se estima que un tercio de las personas que padecen depresión reciben tratamiento y de estos, menos de un tercio presenta mejoría con la terapia. Co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::748c13eb05bbd94e206e1be1a46f3e25
